EV-associated targets with known aptamers
| id | gene_symbol | protein_name | in_cev_map | aptamer_count_pubmed | opentargets_top_disease_name | priority_score |
|---|---|---|---|---|---|---|
| P25445 | FAS | Tumor necrosis factor receptor superfamily member 6 | 1 | 17 | autoimmune lymphoproliferative syndrome type 1 | 0.914 |
| P13747 | HLA-E | HLA class I histocompatibility antigen, alpha chain E | 1 | 1 | COVID-19 | 0.865 |
| O75581 | LRP6 | Low-density lipoprotein receptor-related protein 6 | 1 | 5 | tooth agenesis, selective, 7 | 0.865 |
| Q15848 | ADIPOQ | Adiponectin | 1 | 10 | hearing loss | 0.806 |
| P51679 | CCR4 | C-C chemokine receptor type 4 | 1 | 3 | mycosis fungoides | 0.804 |
| P15260 | IFNGR1 | Interferon gamma receptor 1 | 1 | 2 | disseminated atypical mycobacterial infection | 0.804 |
| P02748 | C9 | Complement component C9 | 1 | 10 | Immunodeficiency due to a late component of complements deficiency | 0.796 |
| P13671 | C6 | Complement component C6 | 1 | 31 | Immunodeficiency due to a late component of complements deficiency | 0.795 |
| Q13085 | ACACA | Acetyl-CoA carboxylase 1 | 1 | 1 | 0.79 | |
| P36888 | FLT3 | Receptor-type tyrosine-protein kinase FLT3 | 1 | 6 | acute myeloid leukemia | 0.788 |
| P04156 | PRNP | Major prion protein | 1 | 2 | Gerstmann-Straussler-Scheinker syndrome | 0.785 |
| Q92633 | LPAR1 | Lysophosphatidic acid receptor 1 | 1 | 1 | Epiretinal membrane | 0.785 |
| P14210 | HGF | Hepatocyte growth factor | 1 | 64 | hearing loss, autosomal recessive | 0.78 |
| P01019 | AGT | Angiotensinogen | 1 | 16 | renal tubular dysgenesis | 0.779 |
| P04839 | CYBB | NADPH oxidase 2 | 1 | 2 | chronic granulomatous disease | 0.776 |
| P61769 | B2M | Beta-2-microglobulin | 1 | 15 | Immunodeficiency by defective expression of HLA class 1 | 0.77 |
| P02776 | PF4 | Platelet factor 4 | 1 | 10 | systemic scleroderma | 0.77 |
| P39060 | COL18A1 | Collagen alpha-1(XVIII) chain | 1 | 2 | Knobloch syndrome 1 | 0.769 |
| P01189 | POMC | Pro-opiomelanocortin | 1 | 1 | obesity due to pro-opiomelanocortin deficiency | 0.76 |
| P05546 | SERPIND1 | Heparin cofactor 2 | 1 | 4 | heparin cofactor 2 deficiency | 0.752 |
| P43007 | SLC1A4 | Neutral amino acid transporter A | 1 | 6 | spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome | 0.75 |
| P08648 | ITGA5 | Integrin alpha-5 | 1 | 2 | skin disease | 0.748 |
| P05164 | MPO | Myeloperoxidase | 1 | 16 | myeloperoxidase deficiency | 0.745 |
| P15144 | ANPEP | Aminopeptidase N | 1 | 1 | cholelithiasis | 0.74 |
| P0C0L4 | C4A | Complement C4-A | 1 | 4 | 0.74 | |
| Q03405 | PLAUR | Urokinase plasminogen activator surface receptor | 1 | 2 | Abdominal Aortic Aneurysm | 0.738 |
| O60884 | DNAJA2 | DnaJ homolog subfamily A member 2 | 1 | 2 | dengue disease | 0.73 |
| P05187 | ALPP | Alkaline phosphatase, placental type | 1 | 7 | male reproductive organ cancer | 0.72 |
| P29622 | SERPINA4 | Kallistatin | 1 | 4 | optic atrophy | 0.719 |
| Q99988 | GDF15 | Growth/differentiation factor 15 | 1 | 29 | hyperemesis gravidarum | 0.718 |
| P05106 | ITGB3 | Integrin beta-3 | 1 | 2 | Glanzmann thrombasthenia 1 | 0.715 |
| P41221 | WNT5A | Protein Wnt-5a | 1 | 4 | Robinow syndrome | 0.71 |
| Q96IY4 | CPB2 | Carboxypeptidase B2 | 1 | 4 | type 2 diabetes mellitus | 0.709 |
| P13987 | CD59 | CD59 glycoprotein | 1 | 1 | primary CD59 deficiency | 0.705 |
| P25311 | AZGP1 | Zinc-alpha-2-glycoprotein | 1 | 1 | neoplasm | 0.701 |
| Q12884 | FAP | Prolyl endopeptidase FAP | 1 | 7 | psoriasis | 0.7 |
| P07225 | PROS1 | Vitamin K-dependent protein S | 1 | 2 | thrombophilia due to protein S deficiency, autosomal dominant | 0.7 |
| P00746 | CFD | Complement factor D | 1 | 4 | recurrent Neisseria infections due to factor D deficiency | 0.695 |
| P00738 | HP | Haptoglobin | 1 | 76 | Hypercholesterolemia | 0.695 |
| P19021 | PAM | Peptidyl-glycine alpha-amidating monooxygenase | 1 | 25 | type 2 diabetes mellitus | 0.695 |
| P21359 | NF1 | Neurofibromin | 1 | 2 | neurofibromatosis type 1 | 0.695 |
| O95858 | TSPAN15 | Tetraspanin-15 | 1 | 1 | venous thromboembolism | 0.692 |
| P00451 | F8 | Coagulation factor VIII | 1 | 13 | hemophilia A | 0.691 |
| P10586 | PTPRF | Receptor-type tyrosine-protein phosphatase F | 1 | 4 | smoking initiation | 0.69 |
| P50148 | GNAQ | Guanine nucleotide-binding protein G(q) subunit alpha | 1 | 1 | Sturge-Weber syndrome | 0.685 |
| P22303 | ACHE | Acetylcholinesterase | 1 | 135 | Alzheimer disease | 0.685 |
| P03950 | ANG | Angiogenin | 1 | 99 | amyotrophic lateral sclerosis | 0.685 |
| P01008 | SERPINC1 | Antithrombin-III | 1 | 11 | hereditary antithrombin deficiency | 0.685 |
| O00501 | CLDN5 | Claudin-5 | 1 | 1 | genetic disorder | 0.685 |
| Q15485 | FCN2 | Ficolin-2 | 1 | 2 | hypopituitarism | 0.682 |
| Q07954 | LRP1 | Prolow-density lipoprotein receptor-related protein 1 | 1 | 3 | developmental dysplasia of the hip | 0.682 |
| P00918 | CA2 | Carbonic anhydrase 2 | 1 | 109 | Osteopetrosis with renal tubular acidosis | 0.68 |
| P13501 | CCL5 | C-C motif chemokine 5 | 1 | 6 | neoplasm | 0.68 |
| P09958 | FURIN | Furin | 1 | 4 | coronary artery disease | 0.68 |
| P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 1 | 17 | WHIM syndrome | 0.68 |
| P12259 | F5 | Coagulation factor V | 1 | 4 | thrombophilia due to activated protein C resistance | 0.68 |
| P14384 | CPM | Carboxypeptidase M | 1 | 3 | hydronephrosis | 0.68 |
| P09382 | LGALS1 | Galectin-1 | 1 | 6 | glaucoma | 0.675 |
| P49913 | CAMP | Cathelicidin antimicrobial peptide | 1 | 30 | prostate carcinoma | 0.675 |
| P09758 | TACSTD2 | Tumor-associated calcium signal transducer 2 | 1 | 4 | gelatinous drop-like corneal dystrophy | 0.673 |
| P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | 1 | 1 | type 2 diabetes mellitus | 0.671 |
| P25942 | CD40 | Tumor necrosis factor receptor superfamily member 5 | 1 | 8 | hyper-IgM syndrome type 3 | 0.67 |
| P08581 | MET | Hepatocyte growth factor receptor | 1 | 149 | papillary renal cell carcinoma | 0.669 |
| P56817 | BACE1 | Beta-secretase 1 | 1 | 9 | metabolic disease | 0.668 |
| P08311 | CTSG | Cathepsin G | 1 | 6 | tuberculosis | 0.667 |
| P01137 | TGFB1 | Transforming growth factor beta-1 proprotein | 1 | 4 | Camurati-Engelmann disease | 0.665 |
| Q9Y251 | HPSE | Heparanase | 1 | 7 | Vitiligo | 0.66 |
| Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | 1 | 1 | Platelet-activating factor acetylhydrolase deficiency | 0.66 |
| P15151 | PVR | Poliovirus receptor | 1 | 3 | Alzheimer disease | 0.66 |
| P16870 | CPE | Carboxypeptidase E | 1 | 16 | BDV syndrome | 0.66 |
| P98155 | VLDLR | Very low-density lipoprotein receptor | 1 | 1 | Dysequilibrium syndrome | 0.66 |
| P22692 | IGFBP4 | Insulin-like growth factor-binding protein 4 | 1 | 6 | allergic rhinitis | 0.66 |
| Q13433 | SLC39A6 | Zinc transporter ZIP6 | 1 | 1 | breast cancer | 0.66 |
| P03952 | KLKB1 | Plasma kallikrein | 1 | 6 | inherited prekallikrein deficiency | 0.656 |
| P02461 | COL3A1 | Collagen alpha-1(III) chain | 1 | 1 | Ehlers-Danlos syndrome, vascular type | 0.656 |
| P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | 1 | 1 | COVID-19 | 0.655 |
| P08709 | F7 | Coagulation factor VII | 1 | 4 | factor VII deficiency | 0.655 |
| Q9Y625 | GPC6 | Glypican-6 | 1 | 1 | autosomal recessive omodysplasia | 0.655 |
| P02766 | TTR | Transthyretin | 1 | 11 | amyloidosis, hereditary systemic 1 | 0.655 |
| P37173 | TGFBR2 | TGF-beta receptor type-2 | 1 | 8 | Loeys-Dietz syndrome | 0.654 |
| Q9H0R3 | TMEM222 | Transmembrane protein 222 | 1 | 3 | neurodevelopmental disorder with motor and speech delay and behavioral abnormalities | 0.654 |
| P36894 | BMPR1A | Bone morphogenetic protein receptor type-1A | 1 | 1 | juvenile polyposis syndrome | 0.653 |
| P02724 | GYPA | Glycophorin-A | 1 | 1 | malaria | 0.653 |
| P62937 | PPIA | Peptidyl-prolyl cis-trans isomerase A | 1 | 1 | HIV infection | 0.652 |
| P60033 | CD81 | CD81 antigen | 1 | 5 | immunodeficiency, common variable, 6 | 0.652 |
| P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 1 | 4 | Adams-Oliver syndrome | 0.652 |
| P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | 1 | 4 | gastrointestinal stromal tumor | 0.652 |
| P32942 | ICAM3 | Intercellular adhesion molecule 3 | 1 | 3 | lymphatic system disease | 0.648 |
| P09104 | ENO2 | Gamma-enolase | 1 | 1 | neurodegenerative disease | 0.645 |
| P07237 | P4HB | Protein disulfide-isomerase | 1 | 2 | Cole-Carpenter syndrome | 0.644 |
| P29323 | EPHB2 | Ephrin type-B receptor 2 | 1 | 1 | medullary thyroid gland carcinoma | 0.643 |
| P01344 | IGF2 | Insulin-like growth factor 2 | 1 | 13 | Silver-Russell syndrome | 0.643 |
| P48740 | MASP1 | Mannan-binding lectin serine protease 1 | 1 | 2 | 3MC syndrome 1 | 0.64 |
| Q14242 | SELPLG | P-selectin glycoprotein ligand 1 | 1 | 1 | glaucoma | 0.64 |
| P06702 | S100A9 | Protein S100-A9 | 1 | 9 | inborn error of immunity | 0.637 |
| P08519 | LPA | Apolipoprotein(a) | 1 | 8 | cardiovascular disease | 0.637 |
| P05109 | S100A8 | Protein S100-A8 | 1 | 5 | inborn error of immunity | 0.635 |
| P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 1 | 2 | progressive supranuclear palsy | 0.635 |
| P01009 | SERPINA1 | Alpha-1-antitrypsin | 1 | 12 | Alpha-1-antitrypsin deficiency | 0.631 |
| P02647 | APOA1 | Apolipoprotein A-I | 1 | 10 | hypoalphalipoproteinemia, primary, 2 | 0.63 |
| P50281 | MMP14 | Matrix metalloproteinase-14 | 1 | 10 | Torg-Winchester syndrome | 0.63 |
| P02788 | LTF | Lactotransferrin | 1 | 3 | tuberculosis | 0.625 |
| P51884 | LUM | Lumican | 1 | 7 | lumbar disc herniation | 0.625 |
| O75976 | CPD | Carboxypeptidase D | 1 | 1 | neurodegenerative disease | 0.625 |
| P49862 | KLK7 | Kallikrein-7 | 1 | 1 | neurodegenerative disease | 0.624 |
| P21926 | CD9 | CD9 antigen | 1 | 17 | diphtheria | 0.623 |
| P21796 | VDAC1 | Non-selective voltage-gated ion channel VDAC1 | 1 | 1 | neurodegenerative disease | 0.621 |
| Q9UNQ0 | ABCG2 | Broad substrate specificity ATP-binding cassette transporter ABCG2 | 1 | 8 | gout | 0.62 |
| P01860 | IGHG3 | Immunoglobulin heavy constant gamma 3 | 1 | 1 | 0.62 | |
| P00749 | PLAU | Urokinase-type plasminogen activator | 1 | 15 | Quebec platelet disorder | 0.62 |
| P16671 | CD36 | Platelet glycoprotein 4 | 1 | 6 | platelet-type bleeding disorder 10 | 0.62 |
| P11279 | LAMP1 | Lysosome-associated membrane glycoprotein 1 | 1 | 1 | thrombophilia | 0.619 |
| Q14623 | IHH | Indian hedgehog protein | 1 | 1 | brachydactyly type A1 | 0.619 |
| O14786 | NRP1 | Neuropilin-1 | 1 | 10 | COVID-19 | 0.619 |
| Q9ULC3 | RAB23 | Ras-related protein Rab-23 | 1 | 1 | RAB23-related Carpenter syndrome | 0.619 |
| P10451 | SPP1 | Osteopontin | 1 | 62 | osteoporosis | 0.615 |
| P01876 | IGHA1 | Immunoglobulin heavy constant alpha 1 | 1 | 2 | IGA glomerulonephritis | 0.612 |
| P02774 | GC | Vitamin D-binding protein | 1 | 295 | vitamin D deficiency | 0.61 |
| P17693 | HLA-G | HLA class I histocompatibility antigen, alpha chain G | 1 | 2 | COVID-19 | 0.61 |
| P01871 | IGHM | Immunoglobulin heavy constant mu | 1 | 3 | agammaglobulinemia | 0.61 |
| P01011 | SERPINA3 | Alpha-1-antichymotrypsin | 1 | 4 | prostate carcinoma | 0.61 |
| P13612 | ITGA4 | Integrin alpha-4 | 1 | 3 | Crohn's disease | 0.61 |
| P00740 | F9 | Coagulation factor IX | 1 | 8 | hemophilia B | 0.61 |
| O43866 | CD5L | CD5 antigen-like | 1 | 3 | functional neutrophil defect | 0.61 |
| O75487 | GPC4 | Glypican-4 | 1 | 1 | Keipert syndrome | 0.61 |
| P23368 | ME2 | NAD-dependent malic enzyme, mitochondrial | 1 | 2 | diabetes mellitus | 0.61 |
| Q12891 | HYAL2 | Hyaluronidase-2 | 1 | 1 | Muggenthaler-Chowdhury-Chioza syndrome | 0.61 |
| P31025 | LCN1 | Lipocalin-1 | 1 | 6 | cervical carcinoma | 0.609 |
| P00450 | CP | Ceruloplasmin | 1 | 130 | aceruloplasminemia | 0.608 |
| P05362 | ICAM1 | Intercellular adhesion molecule 1 | 1 | 43 | neurodegenerative disease | 0.608 |
| P15529 | CD46 | Membrane cofactor protein | 1 | 9 | atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | 0.608 |
| P55157 | MTTP | Microsomal triglyceride transfer protein large subunit | 1 | 1 | abetalipoproteinemia | 0.608 |
| O75508 | CLDN11 | Claudin-11 | 1 | 1 | leukodystrophy, hypomyelinating, 22 | 0.608 |
| P03956 | MMP1 | Interstitial collagenase | 1 | 5 | acne | 0.605 |
| P11166 | SLC2A1 | Solute carrier family 2, facilitated glucose transporter member 1 | 1 | 2 | encephalopathy due to GLUT1 deficiency | 0.605 |
| P01034 | CST3 | Cystatin-C | 1 | 13 | Hereditary cerebral hemorrhage with amyloidosis | 0.605 |
| Q9NZQ7 | CD274 | Programmed cell death 1 ligand 1 | 1 | 67 | non-small cell lung carcinoma | 0.605 |
| P00736 | C1R | Complement C1r subcomponent | 1 | 2 | 0.605 | |
| P36897 | TGFBR1 | TGF-beta receptor type-1 | 1 | 1 | Loeys-Dietz syndrome 1 | 0.605 |
| P27918 | CFP | Properdin | 1 | 18 | Properdin deficiency | 0.605 |
| P01023 | A2M | Alpha-2-macroglobulin | 1 | 2 | refractive error | 0.605 |
| P00742 | F10 | Coagulation factor X | 1 | 8 | factor X deficiency | 0.605 |
| P10646 | TFPI | Tissue factor pathway inhibitor | 1 | 28 | hemophilia A | 0.605 |
| P10909 | CLU | Clusterin | 1 | 5 | Alzheimer disease | 0.605 |
| P01031 | C5 | Complement C5 | 1 | 58 | Immunodeficiency due to a late component of complements deficiency | 0.605 |
| P18615 | NELFE | Negative elongation factor E | 1 | 4 | HIV infection | 0.605 |
| P26006 | ITGA3 | Integrin alpha-3 | 1 | 1 | epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome | 0.605 |
| P46734 | MAP2K3 | Dual specificity mitogen-activated protein kinase kinase 3 | 1 | 1 | neurodegenerative disease | 0.605 |
| P11597 | CETP | Cholesteryl ester transfer protein | 1 | 1 | cholesterol-ester transfer protein deficiency | 0.602 |
| Q01650 | SLC7A5 | Large neutral amino acids transporter small subunit 1 | 1 | 1 | vertebral joint disease | 0.602 |
| Q16270 | IGFBP7 | Insulin-like growth factor-binding protein 7 | 1 | 4 | familial retinal arterial macroaneurysm | 0.602 |
| Q99538 | LGMN | Legumain | 1 | 2 | crush injury | 0.6 |
| P01375 | TNF | Tumor necrosis factor | 1 | 260 | 0.6 | |
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | 1 | 1 | atrial fibrillation | 0.6 |
| P04626 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | 1 | 119 | non-small cell lung carcinoma | 0.6 |
| P46821 | MAP1B | Microtubule-associated protein 1B | 1 | 5 | periventricular nodular heterotopia 9 | 0.6 |
| P43235 | CTSK | Cathepsin K | 1 | 3 | pycnodysostosis | 0.595 |
| P29965 | CD40LG | CD40 ligand | 1 | 6 | hyper-IgM syndrome type 1 | 0.595 |
| P30046 | DDT | D-dopachrome decarboxylase | 1 | 20 | neurodegenerative disease | 0.594 |
| Q7Z3B1 | NEGR1 | Neuronal growth regulator 1 | 1 | 1 | intelligence | 0.594 |
| P55145 | MANF | Mesencephalic astrocyte-derived neurotrophic factor | 1 | 1 | diabetes, deafness, developmental delay, and short stature syndrome | 0.594 |
| P37802 | TAGLN2 | Transgelin-2 | 1 | 3 | neurodegenerative disease | 0.593 |
| Q15438 | CYTH1 | Cytohesin-1 | 1 | 6 | type 2 diabetes mellitus | 0.591 |
| P19022 | CDH2 | Cadherin-2 | 1 | 1 | agenesis of corpus callosum, cardiac, ocular, and genital syndrome | 0.59 |
| Q14515 | SPARCL1 | SPARC-like protein 1 | 1 | 2 | gout | 0.589 |
| P02787 | TF | Serotransferrin | 1 | 114 | atransferrinemia | 0.587 |
| P02786 | TFRC | Transferrin receptor protein 1 | 1 | 3 | TFRC-related combined immunodeficiency | 0.587 |
| P05121 | SERPINE1 | Plasminogen activator inhibitor 1 | 1 | 25 | congenital plasminogen activator inhibitor type 1 deficiency | 0.585 |
| P31948 | STIP1 | Stress-induced-phosphoprotein 1 | 1 | 7 | neurodegenerative disease | 0.585 |
| P13497 | BMP1 | Bone morphogenetic protein 1 | 1 | 1 | osteogenesis imperfecta | 0.585 |
| P02458 | COL2A1 | Collagen alpha-1(II) chain | 1 | 1 | spondyloepiphyseal dysplasia congenita | 0.583 |
| Q15796 | SMAD2 | SMAD family member 2 | 1 | 7 | Loeys-Dietz syndrome 6 | 0.583 |
| Q15813 | TBCE | Tubulin-specific chaperone E | 1 | 1 | hypoparathyroidism-retardation-dysmorphism syndrome | 0.582 |
| Q13287 | NMI | N-myc-interactor | 1 | 2 | type 2 diabetes mellitus | 0.581 |
| P07355 | ANXA2 | Annexin A2 | 1 | 12 | neurodegenerative disease | 0.58 |
| P28907 | CD38 | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 1 | 5 | multiple myeloma | 0.58 |
| Q9H244 | P2RY12 | P2Y purinoceptor 12 | 1 | 2 | platelet-type bleeding disorder 8 | 0.58 |
| Q13724 | MOGS | Mannosyl-oligosaccharide glucosidase | 1 | 3 | MOGS-congenital disorder of glycosylation | 0.58 |
| O95445 | APOM | Apolipoprotein M | 1 | 10 | type 2 diabetes mellitus | 0.58 |
| P12036 | NEFH | Neurofilament heavy polypeptide | 1 | 2 | Charcot-Marie-Tooth disease axonal type 2CC | 0.579 |
| P43652 | AFM | Afamin | 1 | 181 | Abnormality of the skeletal system | 0.575 |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | 1 | 2 | melanoma, cutaneous malignant, susceptibility to, 3 | 0.575 |
| P23508 | MCC | Colorectal mutant cancer protein | 1 | 3 | colon carcinoma | 0.575 |
| O15327 | INPP4B | Inositol polyphosphate 4-phosphatase type II | 1 | 2 | neurodegenerative disease | 0.574 |
| P24394 | IL4R | Interleukin-4 receptor subunit alpha | 1 | 3 | asthma | 0.574 |
| P07550 | ADRB2 | Beta-2 adrenergic receptor | 1 | 2 | asthma | 0.573 |
| Q9UPY5 | SLC7A11 | Cystine/glutamate transporter | 1 | 5 | schizophrenia | 0.573 |
| P06756 | ITGAV | Integrin alpha-V | 1 | 8 | neurodegenerative disease | 0.572 |
| P14174 | MIF | Macrophage migration inhibitory factor | 1 | 2 | rheumatoid arthritis | 0.57 |
| O43854 | EDIL3 | EGF-like repeat and discoidin I-like domain-containing protein 3 | 1 | 1 | COVID-19 | 0.57 |
| P00750 | PLAT | Tissue-type plasminogen activator | 1 | 9 | stroke | 0.57 |
| P00813 | ADA | Adenosine deaminase | 1 | 72 | Severe combined immunodeficiency due to adenosine deaminase deficiency | 0.57 |
| P02654 | APOC1 | Apolipoprotein C-I | 1 | 4 | 0.57 | |
| P26599 | PTBP1 | Polypyrimidine tract-binding protein 1 | 1 | 2 | dengue disease | 0.567 |
| P27487 | DPP4 | Dipeptidyl peptidase 4 | 1 | 4 | type 2 diabetes mellitus | 0.565 |
| P00747 | PLG | Plasminogen | 1 | 51 | hypoplasminogenemia | 0.565 |
| P12273 | PIP | Prolactin-inducible protein | 1 | 7 | neurodegenerative disease | 0.564 |
| Q07352 | ZFP36L1 | mRNA decay activator protein ZFP36L1 | 1 | 1 | neurodegenerative disease | 0.564 |
| P30519 | HMOX2 | Heme oxygenase 2 | 1 | 1 | neuroinflammatory disorder | 0.563 |
| P11274 | BCR | Breakpoint cluster region protein | 1 | 20 | chronic myelogenous leukemia | 0.562 |
| P18206 | VCL | Vinculin | 1 | 4 | hypertrophic cardiomyopathy | 0.56 |
| Q0VDF9 | HSPA14 | Heat shock 70 kDa protein 14 | 1 | 1 | neurodegenerative disease | 0.56 |
| Q03393 | PTS | 6-pyruvoyl tetrahydrobiopterin synthase | 1 | 16 | 0.56 | |
| O75084 | FZD7 | Frizzled-7 | 1 | 2 | Abnormality of the skeletal system | 0.556 |
| Q92743 | HTRA1 | Serine protease HTRA1 | 1 | 1 | cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | 0.556 |
| P12821 | ACE | Angiotensin-converting enzyme | 1 | 108 | diabetic nephropathy | 0.555 |
| P08253 | MMP2 | 72 kDa type IV collagenase | 1 | 20 | Torg-Winchester syndrome | 0.555 |
| P02452 | COL1A1 | Collagen alpha-1(I) chain | 1 | 3 | osteogenesis imperfecta type 2 | 0.555 |
| Q5ZPR3 | CD276 | CD276 antigen | 1 | 1 | response to statin | 0.555 |
| P07947 | YES1 | Tyrosine-protein kinase Yes | 1 | 1 | chronic myelogenous leukemia | 0.554 |
| P21589 | NT5E | 5'-nucleotidase | 1 | 3 | hereditary arterial and articular multiple calcification syndrome | 0.552 |
| Q29983 | MICA | MHC class I polypeptide-related sequence A | 1 | 7 | 0.55 | |
| P32119 | PRDX2 | Peroxiredoxin-2 | 1 | 2 | neurodegenerative disease | 0.55 |
| P02753 | RBP4 | Retinol-binding protein 4 | 1 | 16 | progressive retinal dystrophy due to retinol transport defect | 0.549 |
| P09172 | DBH | Dopamine beta-hydroxylase | 1 | 2 | orthostatic hypotension 1 | 0.547 |
| P14735 | IDE | Insulin-degrading enzyme | 1 | 27 | type 2 diabetes mellitus | 0.545 |
| Q08722 | CD47 | Leukocyte surface antigen CD47 | 1 | 11 | myelodysplastic syndrome | 0.545 |
| P42858 | HTT | Huntingtin | 1 | 18 | Huntington disease | 0.545 |
| O75324 | SNN | Stannin | 1 | 1 | cardiomyopathy | 0.545 |
| P10145 | CXCL8 | Interleukin-8 | 1 | 15 | coronary artery disease | 0.545 |
| P35443 | THBS4 | Thrombospondin-4 | 1 | 3 | Abnormality of the skeletal system | 0.545 |
| Q9P121 | NTM | Neurotrimin | 1 | 2 | smoking initiation | 0.541 |
| P10599 | TXN | Thioredoxin | 1 | 28 | neurodegenerative disease | 0.54 |
| O43493 | TGOLN2 | Trans-Golgi network integral membrane protein 2 | 1 | 1 | osteoporosis | 0.54 |
| P32856 | STX2 | Syntaxin-2 | 1 | 7 | venous thromboembolism | 0.54 |
| P36955 | SERPINF1 | Pigment epithelium-derived factor | 1 | 17 | osteogenesis imperfecta | 0.54 |
| P25774 | CTSS | Cathepsin S | 1 | 11 | basal cell carcinoma | 0.538 |
| P14136 | GFAP | Glial fibrillary acidic protein | 1 | 4 | Alexander disease | 0.537 |
| P16150 | SPN | Leukosialin | 1 | 1 | neurodegenerative disease | 0.533 |
| Q13794 | PMAIP1 | Phorbol-12-myristate-13-acetate-induced protein 1 | 1 | 1 | neurodegenerative disease | 0.533 |
| P80162 | CXCL6 | C-X-C motif chemokine 6 | 1 | 3 | neurodegenerative disease | 0.533 |
| P56199 | ITGA1 | Integrin alpha-1 | 1 | 1 | type 2 diabetes mellitus | 0.531 |
| P21980 | TGM2 | Protein-glutamine gamma-glutamyltransferase 2 | 1 | 1 | neurodegenerative disease | 0.529 |
| P05154 | SERPINA5 | Plasma serine protease inhibitor | 1 | 2 | preeclampsia | 0.529 |
| P01308 | INS | Insulin | 1 | 243 | diabetes mellitus, permanent neonatal 4 | 0.528 |
| A6XGL2 | INS | Insulin | 1 | 243 | diabetes mellitus, permanent neonatal 4 | 0.528 |
| Q9H082 | RAB33B | Ras-related protein Rab-33B | 1 | 3 | Smith-McCort dysplasia 2 | 0.527 |
| P43490 | NAMPT | Nicotinamide phosphoribosyltransferase | 1 | 5 | neurodegenerative disease | 0.525 |
| P17405 | SMPD1 | Sphingomyelin phosphodiesterase | 1 | 1 | Niemann-Pick disease type A | 0.525 |
| P13726 | F3 | Tissue factor | 1 | 36 | cervical cancer | 0.525 |
| P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | 69 | metaphyseal anadysplasia | 0.525 |
| P13591 | NCAM1 | Neural cell adhesion molecule 1 | 1 | 1 | smoking initiation | 0.525 |
| P06744 | GPI | Glucose-6-phosphate isomerase | 1 | 19 | hemolytic anemia due to glucophosphate isomerase deficiency | 0.523 |
| P09871 | C1S | Complement C1s subcomponent | 1 | 1 | Ehlers-Danlos syndrome, periodontal type 2 | 0.52 |
| Q07108 | CD69 | Early activation antigen CD69 | 1 | 5 | hypothyroidism | 0.52 |
| P13688 | CEACAM1 | Cell adhesion molecule CEACAM1 | 1 | 1 | neoplasm | 0.52 |
| P08637 | FCGR3A | Low affinity immunoglobulin gamma Fc region receptor III-A | 1 | 2 | autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity | 0.52 |
| P0CG30 | GSTT2B | Glutathione S-transferase theta-2B | 1 | 26 | neurodegenerative disease | 0.517 |
| O75594 | PGLYRP1 | Peptidoglycan recognition protein 1 | 1 | 2 | dementia | 0.516 |
| Q96RS0 | TGS1 | Trimethylguanosine synthase | 1 | 1 | neurodegenerative disease | 0.514 |
| P26583 | HMGB2 | High mobility group protein B2 | 1 | 1 | neoplasm | 0.511 |
| Q02161 | RHD | Blood group Rh(D) polypeptide | 1 | 4 | Rh deficiency syndrome | 0.508 |
| P99999 | CYCS | Cytochrome c | 1 | 79 | thrombocytopenia 4 | 0.505 |
| P26440 | IVD | Isovaleryl-CoA dehydrogenase, mitochondrial | 1 | 2 | isovaleric acidemia | 0.505 |
| P41217 | CD200 | OX-2 membrane glycoprotein | 1 | 4 | basal cell carcinoma | 0.505 |
| P43251 | BTD | Biotinidase | 1 | 1 | biotinidase deficiency | 0.504 |
| O15067 | PFAS | Phosphoribosylformylglycinamidine synthase | 1 | 10 | dyskeratosis congenita | 0.502 |
| O60784 | TOM1 | Target of Myb1 membrane trafficking protein | 1 | 1 | neurodegenerative disease | 0.502 |
| Q8NF50 | DOCK8 | Dedicator of cytokinesis protein 8 | 1 | 2 | combined immunodeficiency due to DOCK8 deficiency | 0.501 |
| P60763 | RAC3 | Ras-related C3 botulinum toxin substrate 3 | 1 | 1 | neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | 0.5 |
| Q15828 | CST6 | Cystatin-M | 1 | 1 | autosomal recessive hypohidrotic ectodermal dysplasia | 0.5 |
| P50895 | BCAM | Basal cell adhesion molecule | 1 | 2 | metabolic syndrome | 0.5 |
| O75781 | PALM | Paralemmin-1 | 1 | 12 | Anxiety | 0.5 |
| Q9UHD9 | UBQLN2 | Ubiquilin-2 | 1 | 2 | amyotrophic lateral sclerosis type 15 | 0.499 |
| Q8NHS0 | DNAJB8 | DnaJ homolog subfamily B member 8 | 1 | 2 | neurodegenerative disease | 0.497 |
| P50461 | CSRP3 | Cysteine and glycine-rich protein 3 | 1 | 1 | dilated cardiomyopathy 1M | 0.496 |
| P01730 | CD4 | T-cell surface glycoprotein CD4 | 1 | 96 | HIV infection | 0.495 |
| P52926 | HMGA2 | High mobility group protein HMGI-C | 1 | 5 | Silver-Russell syndrome 5 | 0.494 |
| P52594 | AGFG1 | Arf-GAP domain and FG repeat-containing protein 1 | 1 | 1 | nervous system benign neoplasm | 0.494 |
| Q9NXG6 | P4HTM | Transmembrane prolyl 4-hydroxylase | 1 | 1 | hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities | 0.492 |
| Q12979 | ABR | Active breakpoint cluster region-related protein | 1 | 3 | systemic lupus erythematosus | 0.491 |
| Q8NB16 | MLKL | Mixed lineage kinase domain-like protein | 1 | 5 | chronic recurrent multifocal osteomyelitis | 0.49 |
| P12830 | CDH1 | Cadherin-1 | 1 | 4 | CDH1-related diffuse gastric and lobular breast cancer syndrome | 0.49 |
| P35241 | RDX | Radixin | 1 | 2 | hearing loss, autosomal recessive | 0.49 |
| P08842 | STS | Steryl-sulfatase | 1 | 5 | 0.49 | |
| P07998 | RNASE1 | Ribonuclease pancreatic | 1 | 17 | neoplasm | 0.485 |
| Q86WV6 | STING1 | Stimulator of interferon genes protein | 1 | 10 | STING-associated vasculopathy with onset in infancy | 0.485 |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 1 | 2 | rheumatoid arthritis | 0.485 |
| P63098 | PPP3R1 | Calcineurin subunit B type 1 | 1 | 2 | Abnormality of the skeletal system | 0.485 |
| P35354 | PTGS2 | Prostaglandin G/H synthase 2 | 1 | 7 | rheumatoid arthritis | 0.483 |
| P80188 | LCN2 | Neutrophil gelatinase-associated lipocalin | 1 | 25 | psoriasis | 0.482 |
| Q53GL0 | PLEKHO1 | Pleckstrin homology domain-containing family O member 1 | 1 | 2 | neurodegenerative disease | 0.482 |
| Q99733 | NAP1L4 | Nucleosome assembly protein 1-like 4 | 1 | 1 | neurodegenerative disease | 0.48 |
| Q4LDE5 | SVEP1 | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 | 1 | 9 | hypertension | 0.48 |
| Q9BVI4 | NOC4L | Nucleolar complex protein 4 homolog | 1 | 1 | Alzheimer disease | 0.478 |
| Q01518 | CAP1 | Adenylyl cyclase-associated protein 1 | 1 | 1 | neurodegenerative disease | 0.476 |
| P50416 | CPT1A | Carnitine O-palmitoyltransferase 1, liver isoform | 1 | 1 | carnitine palmitoyl transferase 1A deficiency | 0.474 |
| P08865 | RPSA | Small ribosomal subunit protein uS2 | 1 | 1 | familial isolated congenital asplenia | 0.471 |
| O00505 | KPNA3 | Importin subunit alpha-4 | 1 | 1 | spastic paraplegia 88, autosomal dominant | 0.47 |
| P09543 | CNP | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 1 | 9 | myopia 2, autosomal dominant | 0.47 |
| P53365 | ARFIP2 | Arfaptin-2 | 1 | 1 | hepatocellular carcinoma | 0.468 |
| P20794 | MAK | Serine/threonine-protein kinase MAK | 1 | 3 | retinitis pigmentosa | 0.467 |
| P47929 | LGALS7 | Galectin-7 | 1 | 1 | neurodegenerative disease | 0.465 |
| P10643 | C7 | Complement component C7 | 1 | 14 | Immunodeficiency due to a late component of complements deficiency | 0.465 |
| O95487 | SEC24B | Protein transport protein Sec24B | 1 | 1 | atrial heart septal defect | 0.465 |
| P35659 | DEK | Protein DEK | 1 | 14 | atrial fibrillation | 0.464 |
| P05452 | CLEC3B | Tetranectin | 1 | 1 | macular dystrophy, retinal, 4 | 0.46 |
| P69905 | HBA1 | Hemoglobin subunit alpha | 1 | 30 | hemoglobin H disease | 0.457 |
| Q93045 | STMN2 | Stathmin-2 | 1 | 3 | neurodegenerative disease | 0.457 |
| P35625 | TIMP3 | Metalloproteinase inhibitor 3 | 1 | 3 | Sorsby fundus dystrophy | 0.457 |
| P40121 | CAPG | Macrophage-capping protein | 1 | 1 | Sensorineural hearing impairment | 0.455 |
| P62745 | RHOB | Rho-related GTP-binding protein RhoB | 1 | 7 | neurodegenerative disease | 0.455 |
| Q0PNE2 | ELP6 | Elongator complex protein 6 | 1 | 3 | Crohn's disease | 0.452 |
| Q9Y315 | DERA | Deoxyribose-phosphate aldolase | 1 | 2 | mathematical ability | 0.452 |
| Q13308 | PTK7 | Inactive tyrosine-protein kinase 7 | 1 | 110 | neurodegenerative disease | 0.452 |
| Q13443 | ADAM9 | Disintegrin and metalloproteinase domain-containing protein 9 | 1 | 3 | Cone rod dystrophy | 0.452 |
| P02743 | APCS | Serum amyloid P-component | 1 | 13 | AL amyloidosis | 0.45 |
| Q5TA50 | CPTP | Ceramide-1-phosphate transfer protein | 1 | 1 | pachyonychia congenita | 0.45 |
| P02675 | FGB | Fibrinogen beta chain | 1 | 1 | congenital afibrinogenemia | 0.45 |
| Q9GZY8 | MFF | Mitochondrial fission factor | 1 | 2 | Lethal encephalopathy due to mitochondrial and peroxisomal fission defect | 0.45 |
| P32121 | ARRB2 | Beta-arrestin-2 | 1 | 4 | cancer | 0.45 |
| Q12905 | ILF2 | Interleukin enhancer-binding factor 2 | 1 | 2 | neurodegenerative disease | 0.45 |
| P08571 | CD14 | Monocyte differentiation antigen CD14 | 1 | 14 | dengue disease | 0.449 |
| Q9P2X3 | IMPACT | Protein IMPACT | 1 | 704 | cancer | 0.448 |
| Q99969 | RARRES2 | Retinoic acid receptor responder protein 2 | 1 | 2 | Abnormality of the skeletal system | 0.445 |
| P31947 | SFN | 14-3-3 protein sigma | 1 | 2 | neurodegenerative disease | 0.444 |
| Q07075 | ENPEP | Glutamyl aminopeptidase | 1 | 2 | hypertension | 0.44 |
| P29992 | GNA11 | Guanine nucleotide-binding protein subunit alpha-11 | 1 | 1 | Familial isolated hypoparathyroidism | 0.44 |
| P07858 | CTSB | Cathepsin B | 1 | 8 | Alzheimer disease | 0.44 |
| P01848 | TRAC | T cell receptor alpha chain constant | 1 | 8 | 0.44 | |
| Q9P126 | CLEC1B | C-type lectin domain family 1 member B | 1 | 1 | hepatocellular carcinoma | 0.44 |
| Q8TB72 | PUM2 | Pumilio homolog 2 | 1 | 1 | neurodegenerative disease | 0.44 |
| P16455 | MGMT | Methylated-DNA--protein-cysteine methyltransferase | 1 | 4 | Abnormality of the skeletal system | 0.439 |
| Q9P0M6 | MACROH2A2 | Core histone macro-H2A.2 | 1 | 13 | enteritis | 0.437 |
| P24593 | IGFBP5 | Insulin-like growth factor-binding protein 5 | 1 | 4 | hypothyroidism | 0.432 |
| P07996 | THBS1 | Thrombospondin-1 | 1 | 6 | autism spectrum disorder | 0.429 |
| P29317 | EPHA2 | Ephrin type-A receptor 2 | 1 | 16 | Total congenital cataract | 0.427 |
| Q05655 | PRKCD | Protein kinase C delta type | 1 | 2 | autoimmune lymphoproliferative syndrome | 0.427 |
| P01037 | CST1 | Cystatin-SN | 1 | 1 | alcohol drinking | 0.425 |
| P07910 | HNRNPC | Heterogeneous nuclear ribonucleoproteins C1/C2 | 1 | 1 | intellectual developmental disorder, autosomal dominant 74 | 0.423 |
| Q9NRA1 | PDGFC | Platelet-derived growth factor C | 1 | 2 | Abnormality of the skeletal system | 0.422 |
| P42704 | LRPPRC | Leucine-rich PPR motif-containing protein, mitochondrial | 1 | 2 | congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | 0.422 |
| Q07065 | CKAP4 | Cytoskeleton-associated protein 4 | 1 | 9 | smoking initiation | 0.421 |
| P55058 | PLTP | Phospholipid transfer protein | 1 | 2 | familial hyperlipidemia | 0.421 |
| P00480 | OTC | Ornithine transcarbamylase, mitochondrial | 1 | 71 | ornithine carbamoyltransferase deficiency | 0.417 |
| Q01105 | SET | Protein SET | 1 | 556 | intellectual disability, autosomal dominant 58 | 0.417 |
| Q16719 | KYNU | Kynureninase | 1 | 2 | vertebral, cardiac, renal, and limb defects syndrome 2 | 0.415 |
| Q6FI81 | CIAPIN1 | Anamorsin | 1 | 1 | neurodegenerative disease | 0.411 |
| P56470 | LGALS4 | Galectin-4 | 1 | 2 | neurodegenerative disease | 0.41 |
| Q96SW2 | CRBN | Protein cereblon | 1 | 1 | multiple myeloma | 0.401 |
| P06401 | PGR | Progesterone receptor | 1 | 11 | endometriosis | 0.397 |
| P01877 | IGHA2 | Immunoglobulin heavy constant alpha 2 | 1 | 2 | Chronic mucocutaneous candidosis | 0.389 |
| P09769 | FGR | Tyrosine-protein kinase Fgr | 1 | 1 | chronic myelogenous leukemia | 0.389 |
| O60506 | SYNCRIP | Heterogeneous nuclear ribonucleoprotein Q | 1 | 1 | SYNCRIP-related neurodevelopmental disorder | 0.388 |
| P00441 | SOD1 | Superoxide dismutase [Cu-Zn] | 1 | 7 | amyotrophic lateral sclerosis | 0.387 |
| P34949 | MPI | Mannose-6-phosphate isomerase | 1 | 2 | MPI-congenital disorder of glycosylation | 0.385 |
| Q6R327 | RICTOR | Rapamycin-insensitive companion of mTOR | 1 | 2 | lung carcinoma | 0.38 |
| Q8NC44 | RETREG2 | Reticulophagy regulator 2 | 1 | 6 | cyst | 0.378 |
| P08574 | CYC1 | Cytochrome c1, heme protein, mitochondrial | 1 | 1 | Isolated CoQ-cytochrome C reductase deficiency | 0.377 |
| Q8NBP7 | PCSK9 | Proprotein convertase subtilisin/kexin type 9 | 1 | 23 | familial hypercholesterolemia | 0.37 |
| Q96QZ7 | MAGI1 | Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 | 1 | 1 | cervical carcinoma | 0.364 |
| Q13423 | NNT | NAD(P) transhydrogenase, mitochondrial | 1 | 3 | familial glucocorticoid deficiency | 0.364 |
| Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 1 | 1 | neurodevelopmental disorder with language delay and seizures | 0.362 |
| P15559 | NQO1 | NAD(P)H dehydrogenase [quinone] 1 | 1 | 3 | neurodegenerative disease | 0.354 |
| P54578 | USP14 | Ubiquitin carboxyl-terminal hydrolase 14 | 1 | 3 | Abnormality of the skeletal system | 0.339 |
| Q99418 | CYTH2 | Cytohesin-2 | 1 | 2 | neurodegenerative disease | 0.337 |
| P06732 | CKM | Creatine kinase M-type | 1 | 2 | response to statin | 0.335 |
| O00748 | CES2 | Cocaine esterase | 1 | 2 | neurodegenerative disease | 0.33 |
| P15531 | NME1 | Nucleoside diphosphate kinase A | 1 | 1 | placenta praevia | 0.328 |
| P09914 | IFIT1 | Antiviral innate immune response effector IFIT1 | 1 | 1 | neurodegenerative disease | 0.328 |
| P11532 | DMD | Dystrophin | 1 | 32 | Duchenne muscular dystrophy | 0.327 |
| P02686 | MBP | Myelin basic protein | 1 | 21 | alcohol drinking | 0.311 |
| P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | 1 | cancer | 0.304 |
| P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 1 | 3 | ovarian dysfunction | 0.3 |
| P02771 | AFP | Alpha-fetoprotein | 1 | 195 | Congenital deficiency in alpha-fetoprotein | 0.26 |
| P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 1 | 11 | neurodegenerative disease | 0.205 |
| Q16798 | ME3 | NADP-dependent malic enzyme, mitochondrial | 1 | 1 | open-angle glaucoma | 0.203 |
| P61626 | LYZ | Lysozyme C | 1 | 10 | Familial renal amyloidosis | 0.195 |
| P02768 | ALB | Albumin | 1 | 428 | hyperthyroxinemia | 0.14 |
| P60709 | ACTB | Actin, cytoplasmic 1 | 1 | 3 | Baraitser-Winter syndrome 1 | 0.06 |
| P08670 | VIM | Vimentin | 1 | 50 | dengue disease | 0.0 |
| P23526 | AHCY | Adenosylhomocysteinase | 1 | 1 | Psychomotor retardation due to S-adenosylhomocysteine hydrolase deficiency | 0.0 |
| O00244 | ATOX1 | Copper transport protein ATOX1 | 1 | 1 | neurodegenerative disease | 0.0 |
| Q06830 | PRDX1 | Peroxiredoxin-1 | 1 | 1 | Methylmalonic acidemia with homocystinuria, type cblC | 0.0 |
| Q14376 | GALE | UDP-glucose 4-epimerase | 1 | 1 | galactose epimerase deficiency | 0.0 |
| P35270 | SPR | Sepiapterin reductase | 1 | 368 | dopa-responsive dystonia due to sepiapterin reductase deficiency | 0.0 |
| P52209 | PGD | 6-phosphogluconate dehydrogenase, decarboxylating | 1 | 1 | neurodegenerative disease | 0.0 |
| P00915 | CA1 | Carbonic anhydrase 1 | 1 | 2 | altitude sickness | 0.0 |
| O00625 | PIR | Pirin | 1 | 1 | COVID-19 | 0.0 |
| P02792 | FTL | Ferritin light chain | 1 | 1 | hereditary hyperferritinemia with congenital cataracts | 0.0 |
| P60174 | TPI1 | Triosephosphate isomerase | 1 | 1 | triosephosphate isomerase deficiency | 0.0 |
| P05089 | ARG1 | Arginase-1 | 1 | 2 | Argininemia | 0.0 |
| Q99714 | HSD17B10 | 3-hydroxyacyl-CoA dehydrogenase type-2 | 1 | 1 | HSD10 mitochondrial disease | 0.0 |
| P04424 | ASL | Argininosuccinate lyase | 1 | 7 | argininosuccinic aciduria | 0.0 |
| P09960 | LTA4H | Leukotriene A-4 hydrolase | 1 | 1 | small intestine neuroendocrine tumor | 0.0 |
| P39023 | RPL3 | Large ribosomal subunit protein uL3 | 1 | 1 | influenza | 0.0 |
| P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | 1 | 1 | prostate cancer | 0.0 |
| P82921 | MRPS21 | Small ribosomal subunit protein bS21m | 1 | 9 | neurodegenerative disease | 0.0 |
| P38117 | ETFB | Electron transfer flavoprotein subunit beta | 1 | 4 | multiple acyl-CoA dehydrogenase deficiency | 0.0 |
| P04040 | CAT | Catalase | 1 | 123 | acatalasia | 0.0 |
| P08758 | ANXA5 | Annexin A5 | 1 | 2 | habitual abortion | 0.0 |
| P31153 | MAT2A | S-adenosylmethionine synthase isoform type-2 | 1 | 1 | neurodegenerative disease | 0.0 |
| P05091 | ALDH2 | Aldehyde dehydrogenase, mitochondrial | 1 | 1 | alcohol dependence | 0.0 |
| P05413 | FABP3 | Fatty acid-binding protein, heart | 1 | 2 | early-onset non-syndromic cataract | 0.0 |
| P00374 | DHFR | Dihydrofolate reductase | 1 | 6 | constitutional megaloblastic anemia with severe neurologic disease | 0.0 |
| Q96GD0 | PDXP | Chronophin | 1 | 1 | experimental autoimmune encephalomyelitis | 0.0 |
| P27338 | MAOB | Amine oxidase [flavin-containing] B | 1 | 1 | Parkinson disease | 0.0 |
| P68036 | UBE2L3 | Ubiquitin-conjugating enzyme E2 L3 | 1 | 1 | neurodegenerative disease | 0.0 |
| P15090 | FABP4 | Fatty acid-binding protein, adipocyte | 1 | 1 | type 2 diabetes mellitus | 0.0 |
| P32754 | HPD | 4-hydroxyphenylpyruvate dioxygenase | 1 | 2 | Tyrosinemia type 3 | 0.0 |
| P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | 1 | 1 | ovarian cancer | 0.0 |
| O75608 | LYPLA1 | Acyl-protein thioesterase 1 | 1 | 1 | ovarian neoplasm | 0.0 |
| P02794 | FTH1 | Ferritin heavy chain | 1 | 2 | neurodegeneration with brain iron accumulation 9 | 0.0 |
| P78417 | GSTO1 | Glutathione S-transferase omega-1 | 1 | 2 | neurodegenerative disease | 0.0 |
| P84098 | RPL19 | Large ribosomal subunit protein eL19 | 1 | 2 | influenza | 0.0 |
| P52788 | SMS | Spermine synthase | 1 | 3 | syndromic X-linked intellectual disability Snyder type | 0.0 |
| P25787 | PSMA2 | Proteasome subunit alpha type-2 | 1 | 2 | multiple myeloma | 0.0 |
| P55769 | SNU13 | NHP2-like protein 1 | 1 | 2 | atrial fibrillation | 0.0 |
| Q9NPE3 | NOP10 | H/ACA ribonucleoprotein complex subunit 3 | 1 | 1 | dyskeratosis congenita, autosomal recessive 1 | 0.0 |
| P06280 | GLA | Alpha-galactosidase A | 1 | 15 | Fabry disease | 0.0 |
| P11413 | G6PD | Glucose-6-phosphate 1-dehydrogenase | 1 | 3 | anemia, nonspherocytic hemolytic, due to G6PD deficiency | 0.0 |
| P18669 | PGAM1 | Phosphoglycerate mutase 1 | 1 | 1 | neoplasm | 0.0 |
| P10619 | CTSA | Lysosomal protective protein | 1 | 3 | galactosialidosis | 0.0 |
| P08133 | ANXA6 | Annexin A6 | 1 | 1 | systemic lupus erythematosus | 0.0 |
| P12004 | PCNA | DNA sliding clamp PCNA | 1 | 13 | ataxia-telangiectasia-like disorder | 0.0 |
| P00491 | PNP | Purine nucleoside phosphorylase | 1 | 3 | purine nucleoside phosphorylase deficiency | 0.0 |
| P49366 | DHPS | Deoxyhypusine synthase | 1 | 2 | neurodevelopmental disorder with seizures and speech and walking impairment | 0.0 |
| P61981 | YWHAG | 14-3-3 protein gamma | 1 | 1 | genetic developmental and epileptic encephalopathy | 0.0 |
| P04181 | OAT | Ornithine aminotransferase, mitochondrial | 1 | 5 | Gyrate atrophy of choroid and retina | 0.0 |
| P04818 | TYMS | Thymidylate synthase | 1 | 4 | dyskeratosis congenita, digenic | 0.0 |
| P63104 | YWHAZ | 14-3-3 protein zeta/delta | 1 | 2 | neurodegenerative disease | 0.0 |
| P63000 | RAC1 | Ras-related C3 botulinum toxin substrate 1 | 1 | 9 | intellectual disability, autosomal dominant 48 | 0.0 |
| P19784 | CSNK2A2 | Casein kinase II subunit alpha' | 1 | 1 | neurodegenerative disease | 0.0 |
| P60953 | CDC42 | Cell division control protein 42 homolog | 1 | 3 | macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome | 0.0 |
| P61586 | RHOA | Transforming protein RhoA | 1 | 4 | ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies | 0.0 |
| P61964 | WDR5 | WD repeat-containing protein 5 | 1 | 1 | Neurodevelopmental disorder | 0.0 |
| P62241 | RPS8 | Small ribosomal subunit protein eS8 | 1 | 1 | influenza | 0.0 |
| Q9NRX2 | MRPL17 | Large ribosomal subunit protein bL17m | 1 | 5 | neurodegenerative disease | 0.0 |
| P62308 | SNRPG | Small nuclear ribonucleoprotein G | 1 | 5 | neurodegenerative disease | 0.0 |
| P01040 | CSTA | Cystatin-A | 1 | 7 | peeling skin syndrome 4 | 0.0 |
| Q9BYD1 | MRPL13 | Large ribosomal subunit protein uL13m | 1 | 1 | neurodegenerative disease | 0.0 |
| P04179 | SOD2 | Superoxide dismutase [Mn], mitochondrial | 1 | 4 | neurodegenerative disease | 0.0 |
| O75223 | GGCT | Gamma-glutamylcyclotransferase | 1 | 1 | ovarian neoplasm | 0.0 |
| O15382 | BCAT2 | Branched-chain-amino-acid aminotransferase, mitochondrial | 1 | 1 | hypervalinemia and hyperleucine-isoleucinemia | 0.0 |
| O14744 | PRMT5 | Protein arginine N-methyltransferase 5 | 1 | 1 | neurodegenerative disease | 0.0 |
| O15294 | OGT | UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit | 1 | 2 | intellectual disability, X-linked 106 | 0.0 |
| P04062 | GBA1 | Lysosomal acid glucosylceramidase | 1 | 1 | Gaucher disease type 1 | 0.0 |
| P07954 | FH | Fumarate hydratase, mitochondrial | 1 | 4 | hereditary leiomyomatosis and renal cell cancer | 0.0 |
| Q9Y2R5 | MRPS17 | Small ribosomal subunit protein uS17m | 1 | 9 | neurodegenerative disease | 0.0 |
| Q16540 | MRPL23 | Large ribosomal subunit protein uL23m | 1 | 5 | neurodegenerative disease | 0.0 |
| P62910 | RPL32 | Large ribosomal subunit protein eL32 | 1 | 1 | influenza | 0.0 |
| P42336 | PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 1 | 2 | megalencephaly-capillary malformation-polymicrogyria syndrome | 0.0 |
| P23921 | RRM1 | Ribonucleoside-diphosphate reductase large subunit | 1 | 1 | non-small cell lung carcinoma | 0.0 |
| Q13084 | MRPL28 | Large ribosomal subunit protein bL28m | 1 | 5 | Miyoshi myopathy | 0.0 |
| Q15370 | ELOB | Elongin-B | 1 | 1 | HIV infection | 0.0 |
| P10253 | GAA | Lysosomal alpha-glucosidase | 1 | 9 | Glycogen storage disease due to acid maltase deficiency | 0.0 |
| Q5VW32 | BROX | BRO1 domain-containing protein BROX | 1 | 1 | angina pectoris | 0.0 |
| P01111 | NRAS | GTPase NRas | 1 | 2 | Noonan syndrome 6 | 0.0 |
| Q13347 | EIF3I | Eukaryotic translation initiation factor 3 subunit I | 1 | 1 | neurodegenerative disease | 0.0 |
| P23284 | PPIB | Peptidyl-prolyl cis-trans isomerase B | 1 | 3 | osteogenesis imperfecta type 9 | 0.0 |
| P52789 | HK2 | Hexokinase-2 | 1 | 5 | neurodegenerative disease | 0.0 |
| O14980 | XPO1 | Exportin-1 | 1 | 2 | multiple myeloma | 0.0 |
| Q13526 | PIN1 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 1 | Abnormality of the skeletal system | 0.0 |
| P01116 | KRAS | GTPase KRas | 1 | 21 | Noonan syndrome 3 | 0.0 |
| P07902 | GALT | Galactose-1-phosphate uridylyltransferase | 1 | 1 | classic galactosemia | 0.0 |
| A0AVT1 | UBA6 | Ubiquitin-like modifier-activating enzyme 6 | 1 | 1 | neurodegenerative disease | 0.0 |
| Q00535 | CDK5 | Cyclin-dependent kinase 5 | 1 | 4 | Alzheimer disease | 0.0 |
| P00390 | GSR | Glutathione reductase, mitochondrial | 1 | 1 | hemolytic anemia due to glutathione reductase deficiency | 0.0 |
| P16435 | POR | NADPH--cytochrome P450 reductase | 1 | 11 | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | 0.0 |
| F5H747 | UBC | 1 | 9 | HIV infection | 0.0 | |
| Q9BYC9 | MRPL20 | Large ribosomal subunit protein bL20m | 1 | 5 | neurodegenerative disease | 0.0 |
| Q9NYA1 | SPHK1 | Sphingosine kinase 1 | 1 | 1 | neurodegenerative disease | 0.0 |
| P41240 | CSK | Tyrosine-protein kinase CSK | 1 | 1 | cancer | 0.0 |
| P62861 | FAU | Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein | 1 | 7 | neurodegenerative disease | 0.0 |
| Q9P015 | MRPL15 | Large ribosomal subunit protein uL15m | 1 | 5 | neurodegenerative disease | 0.0 |
| Q9C0B1 | FTO | Alpha-ketoglutarate-dependent dioxygenase FTO | 1 | 39 | lethal polymalformative syndrome, Boissel type | 0.0 |
| Q9Y3D3 | MRPS16 | Small ribosomal subunit protein bS16m | 1 | 9 | combined oxidative phosphorylation defect type 2 | 0.0 |
| P06730 | EIF4E | Eukaryotic translation initiation factor 4E | 1 | 6 | neurodegenerative disease | 0.0 |
| O00214 | LGALS8 | Galectin-8 | 1 | 1 | alcohol drinking | 0.0 |
| O15455 | TLR3 | Toll-like receptor 3 | 1 | 7 | Herpetic encephalitis | 0.0 |
| Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | 1 | 1 | neurodegenerative disease | 0.0 |
| O14773 | TPP1 | Tripeptidyl-peptidase 1 | 1 | 2 | neuronal ceroid lipofuscinosis 2 | 0.0 |
| P28482 | MAPK1 | Mitogen-activated protein kinase 1 | 1 | 9 | Noonan syndrome | 0.0 |
| P34947 | GRK5 | G protein-coupled receptor kinase 5 | 1 | 1 | venous thromboembolism | 0.0 |
| P46782 | RPS5 | Small ribosomal subunit protein uS7 | 1 | 1 | influenza | 0.0 |
| Q9NP81 | SARS2 | Serine--tRNA ligase, mitochondrial | 1 | 438 | hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome | 0.0 |
| P11498 | PC | Pyruvate carboxylase, mitochondrial | 1 | 607 | pyruvate carboxylase deficiency disease | 0.0 |
| P27695 | APEX1 | DNA repair nuclease/redox regulator APEX1 | 1 | 7 | neurodegenerative disease | 0.0 |
| P25098 | GRK2 | Beta-adrenergic receptor kinase 1 | 1 | 5 | Jeune syndrome | 0.0 |
| Q9NXA8 | SIRT5 | NAD-dependent protein deacylase sirtuin-5, mitochondrial | 1 | 1 | sleep apnea | 0.0 |
| Q14195 | DPYSL3 | Dihydropyrimidinase-related protein 3 | 1 | 2 | neurodegenerative disease | 0.0 |
| Q15843 | NEDD8 | Ubiquitin-like protein NEDD8 | 1 | 1 | neurodegenerative disease | 0.0 |
| P35520 | CBS | Cystathionine beta-synthase | 1 | 6 | classic homocystinuria | 0.0 |
| P16278 | GLB1 | Beta-galactosidase | 1 | 31 | mucopolysaccharidosis type 4B | 0.0 |
| P53634 | CTSC | Dipeptidyl peptidase 1 | 1 | 1 | Papillon-Lefèvre syndrome | 0.0 |
| Q12933 | TRAF2 | TNF receptor-associated factor 2 | 1 | 2 | genetic disorder | 0.0 |
| Q15369 | ELOC | Elongin-C | 1 | 1 | HIV infection | 0.0 |
| P62805 | H4C1 | Histone H4 | 1 | 5 | infectious disease | 0.0 |
| P62068 | USP46 | Ubiquitin carboxyl-terminal hydrolase 46 | 1 | 1 | male reproductive organ cancer | 0.0 |
| P47897 | QARS1 | Glutamine--tRNA ligase | 1 | 3 | Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome | 0.0 |
| Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | 2 | neurodegenerative disease | 0.0 |
| Q9UHD2 | TBK1 | Serine/threonine-protein kinase TBK1 | 1 | 1 | frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | 0.0 |
| O75844 | ZMPSTE24 | CAAX prenyl protease 1 homolog | 1 | 1 | mandibuloacral dysplasia with type B lipodystrophy | 0.0 |
| P13639 | EEF2 | Elongation factor 2 | 1 | 5 | spinocerebellar ataxia type 26 | 0.0 |
| P39748 | FEN1 | Flap endonuclease 1 | 1 | 13 | neurodegenerative disease | 0.0 |
| P06493 | CDK1 | Cyclin-dependent kinase 1 | 1 | 3 | neurodegenerative disease | 0.0 |
| P32456 | GBP2 | Guanylate-binding protein 2 | 1 | 2 | bacterial disease | 0.0 |
| P06396 | GSN | Gelsolin | 1 | 6 | Finnish type amyloidosis | 0.0 |
| O15264 | MAPK13 | Mitogen-activated protein kinase 13 | 1 | 1 | attention deficit hyperactivity disorder | 0.0 |
| P07332 | FES | Tyrosine-protein kinase Fes/Fps | 1 | 6 | hypertension | 0.0 |
| Q93034 | CUL5 | Cullin-5 | 1 | 1 | HIV infection | 0.0 |
| P0CG48 | UBC | Polyubiquitin-C | 1 | 9 | HIV infection | 0.0 |
| Q96A35 | MRPL24 | Large ribosomal subunit protein uL24m | 1 | 5 | neurodegenerative disease | 0.0 |
| O14966 | RAB29 | Ras-related protein Rab-29 | 1 | 3 | prostate carcinoma | 0.0 |
| P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 1 | 2 | chronic obstructive pulmonary disease | 0.0 |
| P62826 | RAN | GTP-binding nuclear protein Ran | 1 | 46 | HIV infection | 0.0 |
| Q99873 | PRMT1 | Protein arginine N-methyltransferase 1 | 1 | 1 | neurodegenerative disease | 0.0 |
| P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 1 | 3 | dengue disease | 0.0 |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | 1 | 24 | neurodegenerative disease | 0.0 |
| Q9HC16 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | 1 | 1 | HIV infection | 0.0 |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | 1 | bipolar disorder | 0.0 |
| Q9BRX2 | PELO | Protein pelota homolog | 1 | 1 | type 2 diabetes mellitus | 0.0 |
| P16591 | FER | Tyrosine-protein kinase Fer | 1 | 2 | Abnormality of the skeletal system | 0.0 |
| P08246 | ELANE | Neutrophil elastase | 1 | 21 | cyclic hematopoiesis | 0.0 |
| Q99707 | MTR | Methionine synthase | 1 | 1 | methylcobalamin deficiency type cblG | 0.0 |
| P09661 | SNRPA1 | U2 small nuclear ribonucleoprotein A' | 1 | 1 | neurodegenerative disease | 0.0 |
| Q9HAV4 | XPO5 | Exportin-5 | 1 | 2 | neurodegenerative disease | 0.0 |
| Q8TDX7 | NEK7 | Serine/threonine-protein kinase Nek7 | 1 | 1 | lymphatic system disease | 0.0 |
| Q15257 | PTPA | Serine/threonine-protein phosphatase 2A activator | 1 | 1 | Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development | 0.0 |
| O15533 | TAPBP | Tapasin | 1 | 1 | 0.0 | |
| P27708 | CAD | Multifunctional protein CAD | 1 | 19 | congenital disorder of glycosylation type I | 0.0 |
| Q9Y2R9 | MRPS7 | Small ribosomal subunit protein uS7m | 1 | 9 | neurodegenerative disease | 0.0 |
| P62081 | RPS7 | Small ribosomal subunit protein eS7 | 1 | 1 | Blackfan-Diamond anemia | 0.0 |
| P50750 | CDK9 | Cyclin-dependent kinase 9 | 1 | 2 | HIV infection | 0.0 |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | 1 | 8 | polycythemia vera | 0.0 |
| P15498 | VAV1 | Proto-oncogene vav | 1 | 1 | cutaneous Leishmaniasis | 0.0 |
| Q92905 | COPS5 | COP9 signalosome complex subunit 5 | 1 | 1 | Joubert syndrome 21 | 0.0 |
| P26038 | MSN | Moesin | 1 | 65 | combined immunodeficiency due to moesin deficiency | 0.0 |
| O14920 | IKBKB | Inhibitor of nuclear factor kappa-B kinase subunit beta | 1 | 2 | severe combined immunodeficiency due to IKK2 deficiency | 0.0 |
| P22830 | FECH | Ferrochelatase, mitochondrial | 1 | 2 | autosomal erythropoietic protoporphyria | 0.0 |
| P16104 | H2AX | Histone H2AX | 1 | 6 | cancer | 0.0 |
| P84077 | ARF1 | ADP-ribosylation factor 1 | 1 | 3 | periventricular nodular heterotopia 8 | 0.0 |
| P42574 | CASP3 | Caspase-3 | 1 | 71 | neurodegenerative disease | 0.0 |
| Q06124 | PTPN11 | Tyrosine-protein phosphatase non-receptor type 11 | 1 | 1 | Noonan syndrome | 0.0 |
| Q07812 | BAX | Apoptosis regulator BAX | 1 | 21 | T-cell acute lymphoblastic leukemia | 0.0 |
| P49327 | FASN | Fatty acid synthase | 1 | 1 | dengue disease | 0.0 |
| Q08209 | PPP3CA | Protein phosphatase 3 catalytic subunit alpha | 1 | 1 | developmental and epileptic encephalopathy 91 | 0.0 |
| Q13617 | CUL2 | Cullin-2 | 1 | 1 | Crohn's disease | 0.0 |
| P05771 | PRKCB | Protein kinase C beta type | 1 | 1 | acute myeloid leukemia | 0.0 |
| Q6P1L8 | MRPL14 | Large ribosomal subunit protein uL14m | 1 | 5 | neurodegenerative disease | 0.0 |
| Q92769 | HDAC2 | Histone deacetylase 2 | 1 | 2 | neoplasm | 0.0 |
| Q9NWU5 | MRPL22 | Large ribosomal subunit protein uL22m | 1 | 5 | neurodegenerative disease | 0.0 |
| Q5T653 | MRPL2 | Large ribosomal subunit protein uL2m | 1 | 5 | neurodegenerative disease | 0.0 |
| O14727 | APAF1 | Apoptotic protease-activating factor 1 | 1 | 1 | neurodegenerative disease | 0.0 |
| O95786 | RIGI | Antiviral innate immune response receptor RIG-I | 1 | 6 | Singleton-Merten dysplasia | 0.0 |
| P42229 | STAT5A | Signal transducer and activator of transcription 5A | 1 | 2 | cancer | 0.0 |
| Q00534 | CDK6 | Cyclin-dependent kinase 6 | 1 | 2 | small cell lung carcinoma | 0.0 |
| P06576 | ATP5F1B | ATP synthase F(1) complex subunit beta, mitochondrial | 1 | 1 | hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 | 0.0 |
| P41091 | EIF2S3 | Eukaryotic translation initiation factor 2 subunit 3 | 1 | 3 | MEHMO syndrome | 0.0 |
| P35609 | ACTN2 | Alpha-actinin-2 | 1 | 1 | dilated cardiomyopathy 1AA | 0.0 |
| Q9H9Q2 | COPS7B | COP9 signalosome complex subunit 7b | 1 | 1 | head and neck squamous cell carcinoma | 0.0 |
| P43403 | ZAP70 | Tyrosine-protein kinase ZAP-70 | 1 | 4 | combined immunodeficiency due to ZAP70 deficiency | 0.0 |
| P30626 | SRI | Sorcin | 1 | 17 | genetic disorder | 0.0 |
| Q86VX2 | COMMD7 | COMM domain-containing protein 7 | 1 | 1 | androgenetic alopecia | 0.0 |
| Q06187 | BTK | Tyrosine-protein kinase BTK | 1 | 1 | X-linked agammaglobulinemia | 0.0 |
| P52434 | POLR2H | DNA-directed RNA polymerases I, II, and III subunit RPABC3 | 1 | 1 | HIV infection | 0.0 |
| P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 1 | 1 | multiple myeloma | 0.0 |
| P12956 | XRCC6 | DNA repair protein Ku70 | 1 | 2 | HIV infection | 0.0 |
| P35268 | RPL22 | Large ribosomal subunit protein eL22 | 1 | 1 | influenza | 0.0 |
| Q14258 | TRIM25 | E3 ubiquitin/ISG15 ligase TRIM25 | 1 | 1 | dengue disease | 0.0 |
| P43405 | SYK | Tyrosine-protein kinase SYK | 1 | 2 | immunodeficiency 82 with systemic inflammation | 0.0 |
| P49406 | MRPL19 | Large ribosomal subunit protein bL19m | 1 | 5 | neurodegenerative disease | 0.0 |
| Q9GZQ3 | COMMD5 | COMM domain-containing protein 5 | 1 | 1 | neurodegenerative disease | 0.0 |
| Q9Y230 | RUVBL2 | RuvB-like 2 | 1 | 1 | neurodegenerative disease | 0.0 |
| P26196 | DDX6 | Probable ATP-dependent RNA helicase DDX6 | 1 | 2 | intellectual developmental disorder with impaired language and dysmorphic facies | 0.0 |
| Q8NBK3 | SUMF1 | Formylglycine-generating enzyme | 1 | 1 | Multiple sulfatase deficiency | 0.0 |
| P12931 | SRC | Proto-oncogene tyrosine-protein kinase Src | 1 | 19 | cancer | 0.0 |
| Q04837 | SSBP1 | Single-stranded DNA-binding protein, mitochondrial | 1 | 1 | optic atrophy 13 with retinal and foveal abnormalities | 0.0 |
| P06239 | LCK | Tyrosine-protein kinase Lck | 1 | 3 | severe combined immunodeficiency due to LCK deficiency | 0.0 |
| Q9Y3B7 | MRPL11 | Large ribosomal subunit protein uL11m | 1 | 5 | neurodegenerative disease | 0.0 |
| Q9BYD3 | MRPL4 | Large ribosomal subunit protein uL4m | 1 | 5 | neurodegenerative disease | 0.0 |
| P84022 | SMAD3 | SMAD family member 3 | 1 | 6 | Aneurysm - osteoarthritis syndrome | 0.0 |
| Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 1 | 1 | Neurodevelopmental disorder | 0.0 |
| Q9UNP9 | PPIE | Peptidyl-prolyl cis-trans isomerase E | 1 | 1 | dengue disease | 0.0 |
| P27986 | PIK3R1 | Phosphatidylinositol 3-kinase regulatory subunit alpha | 1 | 1 | SHORT syndrome | 0.0 |
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 1 | 1 | cardiofaciocutaneous syndrome | 0.0 |
| P31749 | AKT1 | RAC-alpha serine/threonine-protein kinase | 1 | 5 | Proteus syndrome | 0.0 |
| P13010 | XRCC5 | DNA repair protein Ku80 | 1 | 1 | HIV infection | 0.0 |
| P09601 | HMOX1 | Heme oxygenase 1 | 1 | 6 | heme oxygenase 1 deficiency | 0.0 |
| Q9HD33 | MRPL47 | Large ribosomal subunit protein uL29m | 1 | 5 | Delayed speech and language development | 0.0 |
| P35221 | CTNNA1 | Catenin alpha-1 | 1 | 2 | Butterfly-shaped pigment dystrophy | 0.0 |
| P13984 | GTF2F2 | General transcription factor IIF subunit 2 | 1 | 1 | HIV infection | 0.0 |
| Q9NR28 | DIABLO | Diablo IAP-binding mitochondrial protein | 1 | 2 | autosomal dominant nonsyndromic hearing loss | 0.0 |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | 1 | 1 | neurodegenerative disease | 0.0 |
| Q9Y399 | MRPS2 | Small ribosomal subunit protein uS2m | 1 | 9 | combined oxidative phosphorylation deficiency 36 | 0.0 |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase 1 | 1 | 9 | ovarian cancer | 0.0 |
| P55072 | VCP | Transitional endoplasmic reticulum ATPase | 1 | 1 | inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 | 0.0 |
| P45983 | MAPK8 | Mitogen-activated protein kinase 8 | 1 | 2 | cancer | 0.0 |
| P53355 | DAPK1 | Death-associated protein kinase 1 | 1 | 1 | neurodegenerative disease | 0.0 |
| Q9H2U1 | DHX36 | ATP-dependent DNA/RNA helicase DHX36 | 1 | 1 | Abnormality of the skeletal system | 0.0 |
| Q9Y6K9 | IKBKG | NF-kappa-B essential modulator | 1 | 2 | incontinentia pigmenti | 0.0 |
| Q14790 | CASP8 | Caspase-8 | 1 | 9 | Autoimmune lymphoproliferative syndrome with recurrent viral infections | 0.0 |
| Q07960 | ARHGAP1 | Rho GTPase-activating protein 1 | 1 | 2 | heart disease | 0.0 |
| P82933 | MRPS9 | Small ribosomal subunit protein uS9m | 1 | 9 | neurodegenerative disease | 0.0 |
| P29597 | TYK2 | Non-receptor tyrosine-protein kinase TYK2 | 1 | 1 | immunodeficiency 35 | 0.0 |
| Q8IXJ6 | SIRT2 | NAD-dependent protein deacetylase sirtuin-2 | 1 | 4 | neoplasm | 0.0 |
| P61587 | RND3 | Rho-related GTP-binding protein RhoE | 1 | 1 | azoospermia | 0.0 |
| P45984 | MAPK9 | Mitogen-activated protein kinase 9 | 1 | 1 | cancer | 0.0 |
| P55854 | SUMO3 | Small ubiquitin-related modifier 3 | 1 | 2 | fragile X-associated tremor/ataxia syndrome | 0.0 |
| P28676 | GCA | Grancalcin | 1 | 7 | intelligence | 0.0 |
| P06241 | FYN | Tyrosine-protein kinase Fyn | 1 | 5 | chronic myelogenous leukemia | 0.0 |
| P41743 | PRKCI | Protein kinase C iota type | 1 | 2 | acute myeloid leukemia | 0.0 |
| P55211 | CASP9 | Caspase-9 | 1 | 8 | neurodegenerative disease | 0.0 |
| Q14653 | IRF3 | Interferon regulatory factor 3 | 1 | 5 | Herpetic encephalitis | 0.0 |
| Q12769 | NUP160 | Nuclear pore complex protein Nup160 | 1 | 2 | nephrotic syndrome | 0.0 |
| P11387 | TOP1 | DNA topoisomerase 1 | 1 | 4 | small cell lung carcinoma | 0.0 |
| Q15691 | MAPRE1 | Microtubule-associated protein RP/EB family member 1 | 1 | 1 | neurodegenerative disease | 0.0 |
| O94925 | GLS | Glutaminase kidney isoform, mitochondrial | 1 | 2 | global developmental delay, progressive ataxia, and elevated glutamine | 0.0 |
| Q7RTN6 | STRADA | STE20-related kinase adapter protein alpha | 1 | 7 | polyhydramnios, megalencephaly, and symptomatic epilepsy | 0.0 |
| Q13137 | CALCOCO2 | Calcium-binding and coiled-coil domain-containing protein 2 | 1 | 1 | Abnormality of the skeletal system | 0.0 |
| Q9P289 | STK26 | Serine/threonine-protein kinase 26 | 1 | 3 | hepatocellular carcinoma | 0.0 |
| P24864 | CCNE1 | G1/S-specific cyclin-E1 | 1 | 1 | Abnormality of the skeletal system | 0.0 |
| Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 1 | 1 | chronic lymphocytic leukemia | 0.0 |
| O75534 | CSDE1 | Cold shock domain-containing protein E1 | 1 | 1 | neurodegenerative disease | 0.0 |
| P61011 | SRP54 | Signal recognition particle subunit SRP54 | 1 | 1 | neutropenia, severe congenital, 8, autosomal dominant | 0.0 |
| P49257 | LMAN1 | Protein ERGIC-53 | 1 | 1 | factor V and factor VIII, combined deficiency of, type 1 | 0.0 |
| P53779 | MAPK10 | Mitogen-activated protein kinase 10 | 1 | 1 | gout | 0.0 |
| Q8NE86 | MCU | Calcium uniporter protein, mitochondrial | 1 | 2 | neurodegenerative disease | 0.0 |
| P15927 | RPA2 | Replication protein A 32 kDa subunit | 1 | 1 | neurodegenerative disease | 0.0 |
| Q13330 | MTA1 | Metastasis-associated protein MTA1 | 1 | 1 | neurodegenerative disease | 0.0 |
| P29558 | RBMS1 | RNA-binding motif, single-stranded-interacting protein 1 | 1 | 1 | neurodegenerative disease | 0.0 |
| P51532 | SMARCA4 | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 | 1 | 1 | intellectual disability, autosomal dominant 16 | 0.0 |
| Q9NTZ6 | RBM12 | RNA-binding protein 12 | 1 | 174 | neurodegenerative disease | 0.0 |
| Q86V81 | ALYREF | THO complex subunit 4 | 1 | 1 | 0.0 | |
| P00519 | ABL1 | Tyrosine-protein kinase ABL1 | 1 | 5 | chronic myelogenous leukemia | 0.0 |
| Q9NY12 | GAR1 | H/ACA ribonucleoprotein complex subunit 1 | 1 | 1 | neurodegenerative disease | 0.0 |
| P55957 | BID | BH3-interacting domain death agonist | 1 | 1 | neurodegenerative disease | 0.0 |
| P22681 | CBL | E3 ubiquitin-protein ligase CBL | 1 | 4 | Noonan syndrome-like disorder with juvenile myelomonocytic leukemia | 0.0 |
| Q14103 | HNRNPD | Heterogeneous nuclear ribonucleoprotein D0 | 1 | 4 | dengue disease | 0.0 |
| P29353 | SHC1 | SHC-transforming protein 1 | 1 | 2 | cancer | 0.0 |
| P67809 | YBX1 | Y-box-binding protein 1 | 1 | 9 | dengue disease | 0.0 |
| P19338 | NCL | Nucleolin | 1 | 541 | neurodegenerative disease | 0.0 |
| Q14432 | PDE3A | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A | 1 | 1 | Brachydactyly - arterial hypertension | 0.0 |
| P50402 | EMD | Emerin | 1 | 5 | X-linked Emery-Dreifuss muscular dystrophy | 0.0 |
| Q7Z4V5 | HDGFL2 | Hepatoma-derived growth factor-related protein 2 | 1 | 1 | Miyoshi myopathy | 0.0 |
| P04150 | NR3C1 | Glucocorticoid receptor | 1 | 5 | glucocorticoid resistance | 0.0 |
| Q9Y5A9 | YTHDF2 | YTH domain-containing family protein 2 | 1 | 1 | neurodegenerative disease | 0.0 |
| P46937 | YAP1 | Transcriptional coactivator YAP1 | 1 | 4 | uveal coloboma-cleft lip and palate-intellectual disability | 0.0 |
| Q14444 | CAPRIN1 | Caprin-1 | 1 | 1 | neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline | 0.0 |
| P43694 | GATA4 | Transcription factor GATA-4 | 1 | 1 | atrial septal defect 2 | 0.0 |
| Q13469 | NFATC2 | Nuclear factor of activated T-cells, cytoplasmic 2 | 1 | 1 | hypertension | 0.0 |
| P51608 | MECP2 | Methyl-CpG-binding protein 2 | 1 | 4 | Rett syndrome | 0.0 |
| Q9HC77 | CPAP | Centrosomal P4.1-associated protein | 1 | 1 | autosomal recessive primary microcephaly | 0.0 |
| Q7Z3T8 | ZFYVE16 | Zinc finger FYVE domain-containing protein 16 | 1 | 2 | liver disease | 0.0 |
| P35637 | FUS | RNA-binding protein FUS | 1 | 8 | sporadic amyotrophic lateral sclerosis | 0.0 |
| Q8WZ42 | TTN | Titin | 1 | 1 | dilated cardiomyopathy | 0.0 |
| P78527 | PRKDC | DNA-dependent protein kinase catalytic subunit | 1 | 3 | severe combined immunodeficiency due to DNA-PKcs deficiency | 0.0 |
| P36969 | GPX4 | Phospholipid hydroperoxide glutathione peroxidase GPX4 | 1 | 5 | spondylometaphyseal dysplasia, Sedaghatian type | 0.0 |
| O60315 | ZEB2 | Zinc finger E-box-binding homeobox 2 | 1 | 3 | Mowat-Wilson syndrome | 0.0 |
| O75390 | CS | Citrate synthase, mitochondrial | 1 | 1467 | neurodegenerative disease | 0.0 |
| O75674 | TOM1L1 | TOM1-like protein 1 | 1 | 1 | mitochondrial complex IV deficiency, nuclear type 23 | 0.0 |
| O75821 | EIF3G | Eukaryotic translation initiation factor 3 subunit G | 1 | 1 | narcolepsy-cataplexy syndrome | 0.0 |
| O75828 | CBR3 | Carbonyl reductase [NADPH] 3 | 1 | 38 | prostate carcinoma | 0.0 |
| O94923 | GLCE | D-glucuronyl C5-epimerase | 1 | 1 | Abnormality of the skeletal system | 0.0 |
| P09668 | CTSH | Pro-cathepsin H | 1 | 1 | type 1 diabetes mellitus | 0.0 |
| P09936 | UCHL1 | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | 1 | 2 | early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome | 0.0 |
| P17096 | HMGA1 | High mobility group protein HMG-I/HMG-Y | 1 | 4 | HIV infection | 0.0 |
| P17252 | PRKCA | Protein kinase C alpha type | 1 | 1 | acute myeloid leukemia | 0.0 |
| P36959 | GMPR | GMP reductase 1 | 1 | 1 | hypertrophic cardiomyopathy | 0.0 |
| P42680 | TEC | Tyrosine-protein kinase Tec | 1 | 13 | alopecia areata | 0.0 |
| P45973 | CBX5 | Chromobox protein homolog 5 | 1 | 2 | Abnormality of the skeletal system | 0.0 |
| P48728 | AMT | Aminomethyltransferase, mitochondrial | 1 | 6 | glycine encephalopathy | 0.0 |
| P50897 | PPT1 | Palmitoyl-protein thioesterase 1 | 1 | 2 | neuronal ceroid lipofuscinosis 1 | 0.0 |
| P53701 | HCCS | Holocytochrome c-type synthase | 1 | 3 | Microphthalmia with linear skin defects syndrome | 0.0 |
| P55263 | ADK | Adenosine kinase | 1 | 2 | adenosine kinase deficiency | 0.0 |
| P57075 | UBASH3A | Ubiquitin-associated and SH3 domain-containing protein A | 1 | 1 | rheumatoid arthritis | 0.0 |
| P63172 | DYNLT1 | Dynein light chain Tctex-type 1 | 1 | 1 | dengue disease | 0.0 |
| P83916 | CBX1 | Chromobox protein homolog 1 | 1 | 2 | viral disease | 0.0 |
| P84103 | SRSF3 | Serine/arginine-rich splicing factor 3 | 1 | 2 | open-angle glaucoma | 0.0 |
| Q00341 | HDLBP | Vigilin | 1 | 2 | dengue disease | 0.0 |
| Q06203 | PPAT | Amidophosphoribosyltransferase | 1 | 1 | rheumatoid arthritis | 0.0 |
| Q13043 | STK4 | Serine/threonine-protein kinase 4 | 1 | 1 | combined immunodeficiency due to STK4 deficiency | 0.0 |
| Q13158 | FADD | FAS-associated death domain protein | 1 | 3 | FADD-related immunodeficiency | 0.0 |
| Q15366 | PCBP2 | Poly(rC)-binding protein 2 | 1 | 2 | severe acute respiratory syndrome | 0.0 |
| Q5JSP0 | FGD3 | FYVE, RhoGEF and PH domain-containing protein 3 | 1 | 1 | anaphylaxis | 0.0 |
| Q7L7L0 | H2AC25 | Histone H2A type 3 | 1 | 2 | infectious disease | 0.0 |
| Q8WW12 | PCNP | PEST proteolytic signal-containing nuclear protein | 1 | 1 | asthma | 0.0 |
| Q96I24 | FUBP3 | Far upstream element-binding protein 3 | 1 | 1 | ulna fracture | 0.0 |
| Q96PY5 | FMNL2 | Formin-like protein 2 | 1 | 1 | open-angle glaucoma | 0.0 |
| Q9BUB7 | TMEM70 | Transmembrane protein 70, mitochondrial | 1 | 2 | mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 | 0.0 |
| Q9H8M7 | MINDY3 | Ubiquitin carboxyl-terminal hydrolase MINDY-3 | 1 | 5 | neuroendocrine neoplasm | 0.0 |
| Q9H8W4 | PLEKHF2 | Pleckstrin homology domain-containing family F member 2 | 1 | 1 | Abnormality of the skeletal system | 0.0 |
| Q9UJY5 | GGA1 | ADP-ribosylation factor-binding protein GGA1 | 1 | 2 | azoospermia | 0.0 |
| Q9ULQ1 | TPCN1 | Two pore channel protein 1 | 1 | 1 | placental retention | 0.0 |
| Q9UPU5 | USP24 | Ubiquitin carboxyl-terminal hydrolase 24 | 1 | 1 | metabolic disease | 0.0 |
| Q9Y646 | CPQ | Carboxypeptidase Q | 1 | 1 | risk-taking behaviour | 0.0 |
| A6NDG6 | PGP | Glycerol-3-phosphate phosphatase | 1 | 18 | neurodegenerative disease | 0.0 |
| O14578 | CIT | Citron Rho-interacting kinase | 1 | 11 | autosomal recessive primary microcephaly | 0.0 |
| O15021 | MAST4 | Microtubule-associated serine/threonine-protein kinase 4 | 1 | 1 | Neurodevelopmental disorder | 0.0 |
| O60507 | TPST1 | Protein-tyrosine sulfotransferase 1 | 1 | 1 | smoking initiation | 0.0 |
| O94900 | TOX | Thymocyte selection-associated high mobility group box protein TOX | 1 | 2 | neurodegenerative disease | 0.0 |
| P05165 | PCCA | Propionyl-CoA carboxylase alpha chain, mitochondrial | 1 | 1 | propionic acidemia | 0.0 |
| P12270 | TPR | Nucleoprotein TPR | 1 | 1 | HIV infection | 0.0 |
| P21397 | MAOA | Amine oxidase [flavin-containing] A | 1 | 2 | Brunner syndrome | 0.0 |
| P35475 | IDUA | Alpha-L-iduronidase | 1 | 1 | Scheie syndrome | 0.0 |
| P39880 | CUX1 | Homeobox protein cut-like 1 | 1 | 1 | global developmental delay with or without impaired intellectual development | 0.0 |
| P48637 | GSS | Glutathione synthetase | 1 | 1 | Glutathione synthetase deficiency | 0.0 |
| P49915 | GMPS | GMP synthase [glutamine-hydrolyzing] | 1 | 2 | lupus nephritis | 0.0 |
| P50502 | ST13 | Hsc70-interacting protein | 1 | 2 | neurodegenerative disease | 0.0 |
| P84090 | ERH | Enhancer of rudimentary homolog | 1 | 1 | neurodegenerative disease | 0.0 |
| Q08J23 | NSUN2 | RNA cytosine C(5)-methyltransferase NSUN2 | 1 | 1 | autosomal recessive non-syndromic intellectual disability | 0.0 |
| Q13247 | SRSF6 | Serine/arginine-rich splicing factor 6 | 1 | 1 | dengue disease | 0.0 |
| Q53H12 | AGK | Acylglycerol kinase, mitochondrial | 1 | 1 | Sengers syndrome | 0.0 |
| Q5VT25 | CDC42BPA | Serine/threonine-protein kinase MRCK alpha | 1 | 2 | neurodegenerative disease | 0.0 |
| Q6NUK1 | SLC25A24 | Mitochondrial adenyl nucleotide antiporter SLC25A24 | 1 | 1 | Fontaine progeroid syndrome | 0.0 |
| P06276 | BCHE | Cholinesterase | 1 | 13 | butyrylcholinesterase deficiency | |
| Q13822 | ENPP2 | Autotaxin | 1 | 2 | Abnormality of the skeletal system | |
| P00751 | CFB | Complement factor B | 1 | 3 | ||
| P02679 | FGG | Fibrinogen gamma chain | 1 | 8 | familial dysfibrinogenemia | |
| Q96QC4 | MICA | 1 | 7 | |||
| P07204 | THBD | Thrombomodulin | 1 | 5 | thrombomodulin-related bleeding disorder | |
| P19429 | TNNI3 | Troponin I, cardiac muscle | 1 | 1 | hypertrophic cardiomyopathy | |
| P82664 | MRPS10 | Small ribosomal subunit protein uS10m | 1 | 9 | neurodegenerative disease | |
| O60462 | NRP2 | Neuropilin-2 | 1 | 2 | esophageal disease | |
| P45379 | TNNT2 | Troponin T, cardiac muscle | 1 | 4 | hypertrophic cardiomyopathy | |
| P82914 | MRPS15 | Small ribosomal subunit protein uS15m | 1 | 9 | neurodegenerative disease | |
| P08603 | CFH | Complement factor H | 1 | 4 | complement factor H deficiency | |
| Q15465 | SHH | Sonic hedgehog protein | 1 | 4 | holoprosencephaly 3 | |
| P08174 | CD55 | Complement decay-accelerating factor | 1 | 3 | Protein-losing enteropathy | |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | 1 | 27 | Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome | |
| P17181 | IFNAR1 | Interferon alpha/beta receptor 1 | 1 | 1 | immunodeficiency 106, susceptibility to viral infections | |
| P26358 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 | 1 | 12 | autosomal dominant cerebellar ataxia, deafness and narcolepsy | |
| P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | 10 | growth delay due to insulin-like growth factor I resistance | |
| P78324 | SIRPA | Tyrosine-protein phosphatase non-receptor type substrate 1 | 1 | 1 | type 2 diabetes mellitus | |
| P57764 | GSDMD | Gasdermin-D | 1 | 6 | Oral ulcer | |
| P06729 | CD2 | T-cell surface antigen CD2 | 1 | 86 | rheumatoid arthritis | |
| P06213 | INSR | Insulin receptor | 1 | 14 | Leprechaunism | |
| P02775 | PPBP | Platelet basic protein | 1 | 3 | neoplasm | |
| O00425 | IGF2BP3 | Insulin-like growth factor 2 mRNA-binding protein 3 | 1 | 1 | neurodegenerative disease | |
| Q9HAU5 | UPF2 | Regulator of nonsense transcripts 2 | 1 | 2 | autism spectrum disorder | |
| P01833 | PIGR | Polymeric immunoglobulin receptor | 1 | 2 | clear cell renal carcinoma | |
| P22087 | FBL | rRNA 2'-O-methyltransferase fibrillarin | 1 | 6 | neurodegenerative disease | |
| Q8N884 | CGAS | Cyclic GMP-AMP synthase | 1 | 23 | dengue disease | |
| Q13490 | BIRC2 | Baculoviral IAP repeat-containing protein 2 | 1 | 1 | neurodegenerative disease | |
| P02545 | LMNA | Prelamin-A/C | 1 | 1 | dilated cardiomyopathy | |
| Q14457 | BECN1 | Beclin-1 | 1 | 1 | neurodegenerative disease | |
| P50914 | RPL14 | Large ribosomal subunit protein eL14 | 1 | 1 | influenza | |
| P14635 | CCNB1 | G2/mitotic-specific cyclin-B1 | 1 | 1 | neurodegenerative disease | |
| Q16790 | CA9 | Carbonic anhydrase 9 | 1 | 1 | epilepsy | |
| P01584 | IL1B | Interleukin-1 beta | 1 | 8 | cryopyrin-associated periodic syndrome | |
| Q08345 | DDR1 | Epithelial discoidin domain-containing receptor 1 | 1 | 1 | ||
| P53999 | SUB1 | Activated RNA polymerase II transcriptional coactivator p15 | 1 | 1 | breast carcinoma | |
| Q9NQX4 | MYO5C | Unconventional myosin-Vc | 1 | 1 | type 2 diabetes mellitus | |
| P08575 | PTPRC | Receptor-type tyrosine-protein phosphatase C | 1 | 1 | immunodeficiency 104 | |
| P24928 | POLR2A | DNA-directed RNA polymerase II subunit RPB1 | 1 | 1 | ||
| Q16832 | DDR2 | Discoidin domain-containing receptor 2 | 1 | 1 | spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome | |
| P02649 | APOE | Apolipoprotein E | 1 | 41 | coronary artery disease | |
| Q9H0M0 | WWP1 | NEDD4-like E3 ubiquitin-protein ligase WWP1 | 1 | 1 | gout | |
| P02511 | CRYAB | Alpha-crystallin B chain | 1 | 2 | myofibrillar myopathy 2 | |
| P20936 | RASA1 | Ras GTPase-activating protein 1 | 1 | 1 | capillary malformation-arteriovenous malformation 1 | |
| P01130 | LDLR | Low-density lipoprotein receptor | 1 | 18 | hypercholesterolemia, familial, 1 | |
| P04637 | TP53 | Cellular tumor antigen p53 | 1 | 13 | Li-Fraumeni syndrome | |
| P30530 | AXL | Tyrosine-protein kinase receptor UFO | 1 | 22 | acute myeloid leukemia | |
| P37840 | SNCA | Alpha-synuclein | 1 | 62 | Hereditary late-onset Parkinson disease | |
| Q9BVP2 | GNL3 | Guanine nucleotide-binding protein-like 3 | 1 | 1 | neurodegenerative disease | |
| O14965 | AURKA | Aurora kinase A | 1 | 2 | neurodegenerative disease | |
| Q9NTG7 | SIRT3 | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 1 | 1 | uterine fibroid | |
| O60502 | OGA | Protein O-GlcNAcase | 1 | 1 | atrial fibrillation | |
| O75533 | SF3B1 | Splicing factor 3B subunit 1 | 1 | 1 | chronic lymphocytic leukemia | |
| Q8WTT2 | NOC3L | Nucleolar complex protein 3 homolog | 1 | 1 | hypertension | |
| P11388 | TOP2A | DNA topoisomerase 2-alpha | 1 | 1 | neoplasm | |
| P40189 | IL6ST | Interleukin-6 receptor subunit beta | 1 | 2 | Autosomal recessive hyper-IgE syndrome | |
| P24821 | TNC | Tenascin | 1 | 49 | autosomal dominant nonsyndromic hearing loss | |
| P33316 | DUT | Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial | 1 | 1 | bone marrow failure and diabetes mellitus syndrome | |
| Q05397 | PTK2 | Focal adhesion kinase 1 | 1 | 3 | neurodegenerative disease | |
| P05455 | SSB | Lupus La protein | 1 | 17 | neurodegenerative disease | |
| P98170 | XIAP | E3 ubiquitin-protein ligase XIAP | 1 | 4 | X-linked lymphoproliferative disease | |
| P22607 | FGFR3 | Fibroblast growth factor receptor 3 | 1 | 6 | achondroplasia | |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | 1 | 13 | hypogonadotropic hypogonadism 2 with or without anosmia | |
| Q9Y3A5 | SBDS | Ribosome maturation protein SBDS | 1 | 1 | Shwachman-Diamond syndrome | |
| Q08945 | SSRP1 | FACT complex subunit SSRP1 | 1 | 1 | HIV infection | |
| P17931 | LGALS3 | Galectin-3 | 1 | 4 | Arthropathy | |
| P21802 | FGFR2 | Fibroblast growth factor receptor 2 | 1 | 5 | Crouzon syndrome | |
| P26045 | PTPN3 | Tyrosine-protein phosphatase non-receptor type 3 | 1 | 2 | stomach disease | |
| Q13153 | PAK1 | Serine/threonine-protein kinase PAK 1 | 1 | 2 | intellectual developmental disorder with macrocephaly, seizures, and speech delay | |
| P07602 | PSAP | Prosaposin | 1 | 1 | Gaucher disease due to saposin C deficiency | |
| P22455 | FGFR4 | Fibroblast growth factor receptor 4 | 1 | 2 | cancer | |
| P21580 | TNFAIP3 | Tumor necrosis factor alpha-induced protein 3 | 1 | 2 | autoinflammatory syndrome, familial, Behcet-like 1 | |
| P59665 | DEFA1 | Neutrophil defensin 1 | 1 | 2 | IGA glomerulonephritis | |
| Q15075 | EEA1 | Early endosome antigen 1 | 1 | 1 | neuroinflammatory disorder | |
| Q15303 | ERBB4 | Receptor tyrosine-protein kinase erbB-4 | 1 | 3 | non-small cell lung carcinoma | |
| P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | 1 | 2 | developmental delay, dysmorphic facies, and brain anomalies | |
| P78504 | JAG1 | Protein jagged-1 | 1 | 4 | Alagille syndrome due to a JAG1 point mutation | |
| Q92888 | ARHGEF1 | Rho guanine nucleotide exchange factor 1 | 1 | 6 | immunodeficiency 62 | |
| P07988 | SFTPB | Pulmonary surfactant-associated protein B | 1 | 1 | Neonatal acute respiratory distress with surfactant metabolism deficiency | |
| P11717 | IGF2R | Cation-independent mannose-6-phosphate receptor | 1 | 5 | coronary artery disease | |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | 1 | 2 | common variable immunodeficiency | |
| P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | 1 | 2 | injury | |
| Q92900 | UPF1 | Regulator of nonsense transcripts 1 | 1 | 1 | Global developmental delay | |
| Q9H6X2 | ANTXR1 | Anthrax toxin receptor 1 | 1 | 2 | GAPO syndrome | |
| Q07817 | BCL2L1 | Bcl-2-like protein 1 | 1 | 6 | neurodegenerative disease | |
| P10515 | DLAT | Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial | 1 | 1 | pyruvate dehydrogenase E2 deficiency | |
| Q04206 | RELA | Transcription factor p65 | 1 | 14 | mucocutaneous ulceration, chronic | |
| O00443 | PIK3C2A | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | 1 | 1 | oculocerebrodental syndrome | |
| P58335 | ANTXR2 | Anthrax toxin receptor 2 | 1 | 4 | hyaline fibromatosis syndrome | |
| Q86UW9 | DTX2 | Probable E3 ubiquitin-protein ligase DTX2 | 1 | 3 | neurodegenerative disease | |
| Q12797 | ASPH | Aspartyl/asparaginyl beta-hydroxylase | 1 | 2 | facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome | |
| Q9NNX6 | CD209 | CD209 antigen | 1 | 1 | dengue disease | |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | 1 | 22 | neoplasm | |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor superfamily member 1A | 1 | 1 | TNF receptor 1-associated periodic fever syndrome | |
| Q07955 | SRSF1 | Serine/arginine-rich splicing factor 1 | 1 | 1 | neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities | |
| P30050 | RPL12 | Large ribosomal subunit protein uL11 | 1 | 1 | influenza | |
| P24592 | IGFBP6 | Insulin-like growth factor-binding protein 6 | 1 | 2 | hypertension | |
| Q13554 | CAMK2B | Calcium/calmodulin-dependent protein kinase type II subunit beta | 1 | 2 | intellectual disability, autosomal dominant 54 | |
| P01133 | EGF | Pro-epidermal growth factor | 1 | 34 | cancer | |
| P09038 | FGF2 | Fibroblast growth factor 2 | 1 | 53 | cancer | |
| P11836 | MS4A1 | B-lymphocyte antigen CD20 | 1 | 2 | chronic lymphocytic leukemia | |
| Q9Y3T9 | NOC2L | Nucleolar complex protein 2 homolog | 1 | 1 | neurodegenerative disease | |
| P29590 | PML | Protein PML | 1 | 5 | uterine fibroid | |
| Q13563 | PKD2 | Polycystin-2 | 1 | 3 | polycystic kidney disease 2 | |
| Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 1 | 2 | immunodeficiency 57 | |
| Q06787 | FMR1 | Fragile X messenger ribonucleoprotein 1 | 1 | 9 | fragile X syndrome | |
| Q8N163 | CCAR2 | Cell cycle and apoptosis regulator protein 2 | 1 | 5 | Abnormality of refraction | |
| P22004 | BMP6 | Bone morphogenetic protein 6 | 1 | 1 | Tangier disease | |
| P55265 | ADAR | Double-stranded RNA-specific adenosine deaminase | 1 | 8 | Aicardi-Goutieres syndrome 6 | |
| P27448 | MARK3 | MAP/microtubule affinity-regulating kinase 3 | 1 | 2 | cancer | |
| B7Z5N5 | SMAD2 | Mothers against decapentaplegic homolog | 1 | 7 | Loeys-Dietz syndrome 6 | |
| Q13123 | IK | Protein Red | 1 | 4 | mitochondrial complex I deficiency, nuclear type 13 | |
| O75381 | PEX14 | Peroxisomal membrane protein PEX14 | 1 | 1 | Zellweger syndrome | |
| P09651 | HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 | 1 | 9 | amyotrophic lateral sclerosis | |
| P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | 4 | Noonan syndrome | |
| P23246 | SFPQ | Splicing factor, proline- and glutamine-rich | 1 | 4 | tuberculosis | |
| P05067 | APP | Amyloid-beta precursor protein | 1 | 63 | Alzheimer disease | |
| P04004 | VTN | Vitronectin | 1 | 10 | hypertension | |
| Q13501 | SQSTM1 | Sequestosome-1 | 1 | 4 | amyotrophic lateral sclerosis | |
| Q13283 | G3BP1 | Ras GTPase-activating protein-binding protein 1 | 1 | 2 | neurodegenerative disease | |
| Q16637 | SMN1 | Survival motor neuron protein | 1 | 1 | Proximal spinal muscular atrophy type 3 | |
| Q14498 | RBM39 | RNA-binding protein 39 | 1 | 1 | neurodegenerative disease | |
| Q9UHD8 | SEPTIN9 | Septin-9 | 1 | 1 | neuralgic amyotrophy | |
| Q9NR56 | MBNL1 | Muscleblind-like protein 1 | 1 | 3 | type 2 diabetes mellitus | |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | 1 | 6 | cardiofaciocutaneous syndrome | |
| Q92879 | CELF1 | CUGBP Elav-like family member 1 | 1 | 3 | Abnormality of the skeletal system | |
| P01042 | KNG1 | Kininogen-1 | 1 | 3 | congenital high-molecular-weight kininogen deficiency | |
| O14976 | GAK | Cyclin-G-associated kinase | 1 | 1 | Parkinson disease | |
| O95819 | MAP4K4 | Mitogen-activated protein kinase kinase kinase kinase 4 | 1 | 1 | neurodegenerative disease | |
| Q13263 | TRIM28 | Transcription intermediary factor 1-beta | 1 | 1 | Wilms tumor | |
| Q13148 | TARDBP | TAR DNA-binding protein 43 | 1 | 7 | amyotrophic lateral sclerosis | |
| Q13164 | MAPK7 | Mitogen-activated protein kinase 7 | 1 | 2 | self-injurious ideation | |
| P49023 | PXN | Paxillin | 1 | 1 | atrial fibrillation | |
| P61978 | HNRNPK | Heterogeneous nuclear ribonucleoprotein K | 1 | 3 | Au-Kline syndrome | |
| P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 1 | 5 | Chronic mucocutaneous candidosis | |
| Q9NQX5 | NPDC1 | Neural proliferation differentiation and control protein 1 | 1 | 2 | neurodegenerative disease | |
| O00187 | MASP2 | Mannan-binding lectin serine protease 2 | 1 | 1 | immunodeficiency due to MASP-2 deficiency |